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INTRODUCTION 
 
The right of a woman to a safe, pleasant pregnancy as well as delivery is a very basic  
 
one, and one to which we obstetricians strive every day.  
 
As knowledge advances by leaps and bounds, there is immense progress in our  
 
understanding of pregnancy and its complications. With the availability of better  
 
monitoring and diagnostic tools, pregnancy complications are picked up earlier and  
 
more often. 
 
If prolongation of pregnancy is deemed to be risky, these women are delivered before  
 
their expected date of confinement. They can be offered a vaginal delivery by means  
 
of induction of labour. There is a rising trend in primary caesarean deliveries-  
 
dooming these women to have higher risks in their subsequent pregnancies. 
 
Researchers are always looking at ways to decrease the caesarean section rate, as well  
 
as to shorten duration of labour. 
 
Misoprostol, once feared, is proving more and more to be safe and efficacious when  
 
used judiciously.  Foleys catheter for induction of labour is also making a comeback  
 
in a big way, causing less fetal distress and achieving high rates of vaginal delivery. 
 
Could this combination be synergistic? Could this lead to shorter labour, and less rates  
 
of Caesarean Section? Here lies our clinical question, previously addressed, but never  
 
quite full answered. 
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AIMS AND OBJECTIVES OF THE STUDY 
 
 
Aim: 
 
To compare the efficacy of Foleys catheter with Misoprostol (combination) versus 
Misoprostol alone for the prupose of induction of labour.  
 
 
 
 
Objectives:  
 
To determine whether use of Foleys in combination with Misoprostol, as opposed to  
 
Misoprostol alone, for induction of labour will lead to 
 
i. Decreased induction to delivery interval 
ii. Higher probability of achieving vaginal delivery 
iii. Lower incidence of Caesarean section 
iv. Affect the rates of meconium stained liqour 
v. Lower rates of hyperstimulation 
vi. Affect incidence of chorioamnionitis/ endomyometritis 
vii. Lower rates of atonic post partum haemorrhage 
viii. Affect neonatal morbidity 
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Introduction 
 
Induction of labour is the stimulation of uterine contractions before the spontaneous  
 
onset of labour, in the presence or absence of membranes (1).  
 
Induction of labour is indicated in cases where continuation of pregnancy poses more  
 
risk than benefit to the mother or/and fetus. Some examples of these situations are,  
 
rupture of membranes before the start of uterine contractions, oligohydramnios,  
 
gestational hypertension, intrauterine growth restriction, maternal indications such as  
 
diabetes mellitus/ chronic hypertension (2). Easy availability of ripening agents, and  
 
patient  request also play an important role in increasing rates of induction of labour  
 
(3).  Electively inducing labour for convenience to the obstetricians schedule has also  
 
been recognized as a major contributing factor (4). 
 
 
Induction of labour at term: Continuation of pregnancy beyond 42 weeks is  
 
associated with complications to the mother and the fetus.  A Cochrane review studied  
 
22 trials that induced labour between 37 and 42 weeks of gestation, compared to  
 
waiting for spontaneous labour  (5). It was found that earlier induction resulted in  
 
fewer perinatal deaths, less meconium aspiration and fewer caesareans than the policy  
 
of waiting.  A systematic review by Caughey et al which included 11 randomised  
 
control trials suggested that elective induction of labour after 41 weeks resulted in a  
 
decreased risk for caesarean delivery and meconium stained amniotic fluid (6). 
 
 
Prevalence of Induction of Labour: Induction rates seem to have increased in the  
 
last decade. A study done in the US showed that the rate of induction of labour has  
 
increased nationwide from 9.5% to 19.4% between the years 1990 and 1998 (3).  
 
16 
 
Increased rates of medically indicated inductions did not contribute to this rise as  
 
much as marginally indicated, or elective inductions. These contribute to at least half  
 
of all inductions, and induction of labour in nulliparas with an unfavourable cervix  
 
results in rising rates of caesarean sections (7). 
 
A national survey was done in the USA by Childhood Connection to ascertain the  
 
experiences of women during pregnancy and labour (8) . 2400 women completed a  
 
detailed online questionnaire. 41% of these women underwent induction of labour.  
 
The most common rationale given to these mothers for inducing labour was that the  
 
baby was overdue (18%), and a maternal health problem that required a quick delivery  
 
(18%).  
 
 
In Christian Medical College, Vellore, incidence of induction of labour whenever  
indicated, is about 15- 20%. The rate of primary LSCS is about 18-24%, failed  
induction accounting for 6-10% of cases.  
 
 
Why is Induction of labour so important? 
 
The increase in LSCS rate has been a global phenomenon.  From the year 1970 to  
 
2010, the rate of caesareans in the USA has risen from 4.5% of all deliveries to 32.8%  
 
(9).  LSCS rate in England is 21.5 % (10), and in Latin American countries around  
 
40 % (11). World Health Organization advises that Cesarean Section (CS) rates  
 
should not be more than 15%. There is evidence that CS rates above 15% are not  
 
associated with additional reduction in maternal and neonatal mortality and morbidity  
 
(12). 
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To make the number of elective/ marginally indicated inductions safer, it is imperative  
 
to find means of induction of labour that have the greatest success rate.  
 
And such safe methods of induction of labour will lower caesarean deliveries and its  
 
added  complications. 
 
 
Methods of Induction of Labour: Many women in whom induction of labour is  
 
indicated have an unfavourable cervix. Thus, much research has dealt with ways to  
 
„ripen‟ the cervix before stimulating uterine contractions. 
 
These methods are: 
 
 Pharmacological Methods: Prostaglandin E2, Prostaglandin E1,Prostaglandin  
 
F2alpha,  Nitric Oxide Donors 
 
 Mechanical Methods: Transcervical catheter, Hygroscopic Cervical Dilators,  
 
Stripping of membranes 
 
These methods alone have been extensively studied, with evidence supporting their  
 
use.  
 
Prostaglandin E1 acts by modifying collagen and alters concentration of  
 
glycosaminoglycans in the cervix. It has been found to shorten induction to  
 
delivery interval, decrease the need for oxytocin administration, and achieve more  
 
vaginal deliveries within 24 hours as compared to other prostaglandins (13). 
 
Intracervical placement of Foleys catheter for the purpose of mechanical ripening of  
 
the cervix was first described in 1967 (14). It acts by local dilatation of the cervix, and  
 
also by stimulating the release of endogenous prostaglandins and oxytocin (15). 
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The prospect of combining mechanical and pharmacological methods is a challenging  
 
one, and has not been studied in systematic randomized control trials. 
 
In a meta-analysis done by Chen et al. (16), eight trials were analysed – a total of 1153  
 
patients. These studies sought to compare Foleys plus Misoprostol versus Misoprostol  
 
alone for ripening of the cervix. The group that used both methods of induction  
 
together had decreased time from induction to delivery intervals (mean difference – 
 
2.36 hours, 95% confidence interval [CI] –4.07 to –0.66; P = 0.007). However, the  
 
risk of chorioamnionitis was found to be higher in the combination group (risk ratio  
 
[RR]2.07, 95% CI 1.04–4.13; P = 0.04). Risk of tachysystole and non reassuring fetal  
 
status was decreased (RR 0.58, 95% CI 0.38–0.91; P = 0.02). The caesarean rates did  
 
not differ in the two groups (p=0.77). 
 
The authors concluded that the combined use of these methods lead to a decreased  
 
induction to delivery interval, less tachsystole and fetal heart rate changes but an  
 
increased rate of chorioamnionitis. 
 
However many of these trials were underpowered.  None of them clearly state the  
 
difference in improvement in caesarean section rate. 
 
This trial is planned to clearly elucidate if there are any, benefits of combining  
 
Foleys and Misoprostol versus Misoprostol alone for ripening of the cervix for  
 
induction of labour. 
 
 
Induction of Labour 
 
Induction of labour refers to the artificial stimulation of uterine contractions to cause  
 
delivery before labour spontaneously sets in.  Closed, uneffaced cervix leads to  
 
prolonged latent phase and labour itself. Cervical ripening is the process by which the  
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cervix is softened and effaced leading to shorter labour. The cervix can be ripened by  
 
pharmacological as well as mechanical methods. 
 
Guidelines for induction of labour 
 
National Institute for Health Care and Excellence (NICE) guidelines (July 2008)(17) 
 
Women must be counseled that most pregnant women will experience spontaneous  
 
labour by 42 weeks. At 38 weeks, during antenatal check up, women should be  
 
informed about risks associated with post term pregnancies, and the options that are  
 
available. 
 
This counseling should cover 
 
 Sweeping of membranes 
 Inducing labour between 41+0 and 42+0 weeks 
 expectant management. 
 
When offering induction of labour, key counseling points are 
 
 Why induction is necessary 
 The method of induction planned 
 Pain relief and support available 
 Alternate options if she is not willing for induction of labour 
 Risks and benefits of the proposed methods of induction 
 That induction is not always successful 
 
Healthcare workers must remember to 
 
 Allow the woman and her partner to come to their own decision 
 Invite questions from the patient and her partner 
 Support the patient whatever may be her decision 
 
 
 
20 
 
Recommended methods for induction of labour 
 
 Sweeping of membranes 
 Pharmacological methods 
 Prostaglandin E2: Is the preferred method 
 Misoprostol (Prostaglandin E1) should only be used in cases of 
intrauterine death. 
 
Mechanical Methods: Balloon catheters are not routinely recommended for induction  
 
of labour.  
 
 
The Society of Obstetricians and Gynaecologists of Canada (SOGC) Guidelines (18) 
 
 Prostaglandins (vaginal and cervical), are effective in the use of ripening the 
cervix and inducing labour when cervix is unfavourable. 
 
 Vaginal prostaglandins are preferred as they are able to achieve more timely 
vaginal deliveries than intra-cervical prostaglandins. 
 
 Indication for induction of labour should be documented. Discussion should 
comprise the method for induction, the reason for induction and risks involved. 
These should cover the possibility of failure to commence labour, and well as 
increased risk for Caesarean delivery. 
 
 When induction of labour is unsuccessful, the method and indication for 
induction must be re-evaluated. 
 
 Induction should not be undertaken solely for provider/ patient preferences. 
 
 Health care providers should use the Bishops score to assess the cervix 
favourability- both to determine method of induction, as well to predict the 
likelihood of success. Bishops score must be carefully documented. 
 
 Women between the gestational ages of 41+0 and 42+0 should be offered 
induction of labour. This may decrease meconium aspiration syndrome as well 
as perinatal mortality rates without increasing the caesarean section rates. 
 
 Those patients that decline induction at >41 weeks should be closely monitored 
twice a week for fetal well being. 
 
 Use of Foleys catheter intracervically for induction is acceptable, both as an 
outpatient procedure, as well as for induction of labour for vaginal birth after 
Caesarean section. 
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 Prostaglandins should not be used for vaginal births after Caesarean section as 
this increases the risk of scar rupture. 
 
 Misoprostol can be both safe and effective for induction when membranes are 
intact, and on an inpatient basis. 
 
 
Indications for Induction of Labour 
 
 Post term pregnancies 
 Prelabour rupture of membranes 
 Preterm prelabour rupture of membranes 
 Abruptio Placenta 
 Intrauterine fetal demise 
 Oligohydramnios 
 Preclampsia, Eclampsia, HELLP 
 Cholestasis of pregnancy 
 Fetal growth Restriction 
 Twin gestation 
 Maternal Diabetes 
 
 
 
Marginally indicated induction/ Elective induction of labour at term:  
 
Elective or “social” induction is associated with many concerns such as increased risk  
 
of Caesarean sections in the latent phase, increased duration of labour and neonatal  
 
morbidity if done before 39 weeks (19) . The potential benefits of induction of labour  
 
at term include reduced rates of macrosomia and its complications, rates of still births  
 
and passage of meconium (but not rates of meconium aspiration) (20,21) . The risk of  
 
sudden, unattended labour is reduced in women who have a history of precipitate  
 
labour. Elective labour also decreases the chances of disrupting the patients/providers  
 
work and home responsibilities. However, most experts agree that elective induction  
 
should not be done before 39 weeks of gestation.  ACOG cautions that rates of   
 
morbidity and mortality are much greater among infants and neonates that delivered  
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during early term compared with those that delivered between 39 and 40 weeks of  
 
gestation (22) . However they also stress that this should not dissuade health care  
 
professionals from carrying out indicated early term inductions, and benefits of early  
 
induction versus risks of prolonging pregnancy should be carefully weighed before  
 
coming to a decision. 
 
There is no consensus however on elective induction of labour from 39 to 41 weeks. A  
 
randomized control trial done showed no additional risk of caesarean, or adverse  
 
maternal/ neonatal short term outcomes with induction at this gestation(23).  
 
Contraindictions to Induction of Labour: These comprise conditions that preclude  
 
labour/ vaginal delivery.  
 
Some examples are- 
 
 Prior Uterine Incision in the upper segment. 
 Contracted pelvis 
 Placenta praevia – major degree 
 Active genital herpes 
 Cervical cancer 
 Fetal macrosomia 
 Non reassuring fetal status 
 Malpresentation 
 Severe hydrocephalus 
 
Techniques for induction of labour 
 
For decades, oxytocin has been used to augment and induce labour. Other drugs that  
 
are newer to armamentarium are Prostaglandins E1 and E2. Mechanical methods are  
 
available, such as intracervical balloon dilators, hygroscopic dilators, amniotomy,  
 
stripping of membranes. ACOG 2012 recommends that each obstetrician/ Hospital  
 
have their own written guidelines and protocols for the induction and augmentation of  
 
labour. 
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Predicting successful induction of labour 
 
Prediction of successful induction of labour depends on several factors such as : 
 
 Maternal factors – Age, parity, status of membranes, Bishops score, gestational 
age, maternal body mass index, maternal height. 
 Fetal factors- estimated fetal weight 
 Placental  factors- Presence/ absence of placental insufficiency 
 
Studies have shown that rates of live vaginal births were found to increase as  
 
gestational age increases. Feghali et al in 2015 studied women being induced  
 
for medical reasons at <37 weeks of gestational age. They divided the patients into  
 
groups according to gestational age (group A- 24-27+6 weeks; B- 28-30+6 weeks; C-  
 
31-33+6 weeks; and D- 34-36+6 weeks). They found that as one progressed from  
 
group A to group D, incidences of vaginal live births increased from 35% (in group A)  
 
to 75% ( in group D) (24). In the same study, when looking at labour curves for  
 
nulliparous women, it was found that as gestational age decreases, the overall duration  
 
of labour increases. However, the duration of the active phase seemed to remain the  
 
same across gestational age. 
 
Multiparous women with favourable cervix at the start of induction had higher  
 
chances of achieving vaginal delivery. The Bishops score in particular is a useful tool  
 
for predicting vaginal delivery, and should routinely be used to assess favourability of  
 
the cervix prior to induction of labour. 
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Modified Bishops score(25) 
 
Cervical feature  Modified Bishop score 
0 1 2        3 
Dilation (cm) < 1 1–2 2–4      > 4 
Length of cervix 
(cm) 
> 4 2–4 1–2      < 1 
Station (relative to 
ischial spines) 
−3 −2 −1/0    +1/+2 
Consistency Firm Average Soft           – 
Position Posterior Mid/anterior –        – 
 
  
 
Bishops Score comprises of 5 parts: effacement or length of cervix , dilatation of  
 
cervix, its consistency and position, the station of the presenting part in relation to the  
 
ischial spines. This score was originally described in multiparous women .  
 
Vrouenraets et al., 2005 have shown a good correlation with a favourable Bishops  
 
score prior to induction and rates of successful induction of labour (26). 
 
A Bishops score of >8 is predictive of successful vaginal birth.  Systematic reviews of  
 
randomized controlled trial have shown that the Bishops score seems to be the most  
 
superior tool for predicting successful induction. Dilatation seems to be the most  
 
important component of Bishops score (27). 
 
Other tools which can be used to assess favorability of the cervix are Fields system  
 
and Burnett, Caldor, and Friedman modifications of the Bishop system. 
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Risks of Induction of Labour 
 
Inducing labour is not without risk, and these should be discussed with the patient and  
 
documented before the process is initiated. 
 
The risks can be divided into 
 
 Maternal: Higher rates of  Caesarean section, chorioamnionitis, rupture of 
uterine scar and uterine atony post delivery leading to post partum 
haemorrhage. 
 
 Fetal: Fetal distress, neonatal infection 
Caesarean Section delivery rate 
 
Caesarean delivery rate is widely believed to be increased in nulliparas undergoing  
 
induction of labour. Maslow and Sweeny, 2000 have reported the risk being two to  
 
three fold higher in this population (28) . As stated before, these rates seem to be  
 
inversely related to the Bishops score at the beginning of induction. In fact, Mercer et  
 
al have found that in nulliparous women with an unfavourable cervix, preinduction  
 
ripening doesn‟t show much benefit in decreasing caesarean section rates (29) . The  
 
station of the fetal head may also be an important contributing factor. Shin et al found  
 
that nulliparas more than 41 weeks of gestation with an unengaged vertex had a 12  
 
fold increase risk of caesarean delivery than those with an engaged vertex(30) . 
 
Of late, there have been arguments against the premise that women undergoing an  
 
elective induction of labour have higher rates of caesarean deliveries. A Cochrane  
 
review published in 2012 was undertaken to address the benefits/ harms of labour  
 
induction at term/ post-term compared to inducing labour later or awaiting  
 
spontaneous labour (31) . In 21 trials, comprising 8749 women, they found that there  
 
were fewer caesarean deliveries for the induction of labour arms compared to a policy  
 
of awaiting spontaneous labour (RR 0.89, 95% CI 0.81 to 0.97). 
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Saconne et al (32) undertook a meta-analysis which was published in 2015 to evaluate  
 
the potential risk of caesarean delivery, and also maternal /perinatal morbidity in  
 
induction of labour for uncomplicated term singleton pregnancies. They studied  
 
randomized control trials which included uncomplicated singleton pregnancies at full  
 
term gestation (39+0 weeks to 40+6 weeks), with intact membranes,  
 
randomized to induction of labour versus expectant management. Primary outcome  
 
studied was incidence of caesarean deliveries. They analysed 5 RCTs comprising 844  
 
women. The authors found that Caesarean section incidence in those that underwent  
 
induction of labour were similar as compared to controls (9.7% vs 7.5%; RR, 1.25;  
 
95% CI, 0.75-2.08).  
 
Secondary analysis of the DIGITAT (fetal growth restriction) and HYPITAT  
 
(hypertension in pregnancy) trials was done. It was found that in women with a  
 
Bishops score of a median of 3 who were induced at term, there was no increase in  
 
incidence of caesarean delivery as compared to expectant management.  
 
Approximately 85% of patients in both arms  achieved a vaginal delivery (33) . Thus  
 
caesarean rates at term may not be dependent on Bishops score at inuduction. 
 
Chorioamnionitis 
 
Amniotomy is associated with a higher incidence of chorioamnionitis  
 
as compared to other methods of induction of labour  (ACOG, 2013a)  (32). 
 
 
Rupture of a prior Uterine Incision 
 
Induction of labour in a woman with a prior scar can be catastrophic. For such  
 
women, even in spontaneous labour , there is a risk of scar rupture which is three-fold.  
 
When prostaglandins and oxytocin are used in these women, the risk is 15.6 fold,  
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when oxytocin alone is used, it is fivefold (34) . ACOG advises against the use of  
 
prostaglandins in induction of labour in women with a scarred uterus. Foleys catheter  
 
can be used for this purpose. 
 
Uterine Atony 
 
Induction of labour can lead to an atonic uterus and postpartum haemorrhage. This can  
 
lead to intractable bleeding, and in certain cases, peripartum hysterectomy. 
 
A study by Hernandez et al in Parkland Hospital showed that induction of labour was  
 
associated with 17% of the 553 women who had peripartum hysterectomies (35) .  
 
There has been an increase in the total peripartum hysterectomies in the USA, rising  
 
from 71.6 to 82.6 per 100,000 deliveries from 1994-1995 to 2006-2007. This rise has  
 
been attributed to rising rates of induction of labour, as well as increased rates of  
 
primary/ repeat caesarean sections (36) . 
 
 
Infant Morbidity 
 
Induction of labour in early term gestations (37 to 38+6 weeks) leads to greater  
 
neonatal morbidity and greater utilization of health care services during the first year  
 
of life(37). This may not be true for those babies induced after 39 weeks, there is not  
 
much data to prove/disprove the same. 
 
Fetal Distress 
 
Injudicious use of Prostaglandins can lead to uterine tachysystole which may vary  
 
from 3-20% (38) .This decreases placental flow and can lead to fetal compromise,  
 
which is especially important in the background of fetal growth restriction. Studies  
 
comparing Misoprostol to Dinoprostone have not found much of a difference in rates  
 
of non reassuring fetal status between the two groups (39).  
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Preinduction Cervical Ripening 
 
The „favourability‟ of the cervix is an important factor when predicting the success of  
 
induction of labour. When cervix is unfavourable, there are a number of  
 
pharmacological and mechanical methods which can be used to make the cervix more  
 
favourable. 
 
 
These methods are: 
 
 Pharmacological Methods: Prostaglandin E2, Prostaglandin E1, Nitric Oxide 
Donors, Oxytocin 
 Mechanical Methods: Transcervical catheter, Hygroscopic Cervical Dilators, 
Stripping of membranes, Amniotomy 
 
Pharmacological Techniques 
 
 Prostaglandin E1 : Misoprostol is a Prostaglandin E1 analogue that has been  
 
approved in the strength of 100 – 200 mcgm to aid in peptic ulcer disease. It is not  
 
FDA approved for the use of induction of labour. However it is widely used as an  
 
abortifacient and in low dose as an agent for induction of labour in developing  
 
countries as the cost is low. An advantage is that the tablets are stable when kept at  
 
room temperature.  
 
However ACOG (2013b) has reaffirmed the use of the drug for use of labour  
 
induction/ abortion due to its proven safety profile, as well as efficacy. It is the drug of  
 
choice for induction of labour at our institution. 
 
Vaginal Administration: Many trials have been carried out, where Misoprostol has  
 
been shown to be equally, if not more efficacious than Dinoprostone for the induction  
 
of labour. 
 
A Cochrane review studied 121 trials. There was a risk of bias, as only 13 of these  
 
were double blind. Misprostol was found to be associated with reduced failure to  
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achieve vaginal delivery when compared to placebo (average relative risk (RR) 0.51,  
 
95% confidence interval (CI) 0.37 to 0.71). There was however, a higher risk of  
 
hyperstimulation, albeit without fetal heart rate changes. When compared to PGE2,  
 
Misoprostol had less incidence of epidural analgesia usage, more hyperstimulation, a  
 
higher incidence of meconium stained liquor and less failure to achieve vaginal  
 
delivery (13) . 
 
Oral Misoprostol: Misoprostol is also effective as an oral agent, and has been found to  
 
be associated with less tachysystole/ fetal heart changes. A Cochrane review studied  
 
the use of oral Misoprostol for induction of labour. The reviewers were able to include  
 
76 trials (14,412 women). These trials were of mixed quality. There were 9 trials  
 
(1109 women), that compared oral Misoprostol to placebo. They found that women  
 
who were given oral Misoprostol were  more likely to achieve vaginal delivery within  
 
24 hours  (risk ratio (RR) 0.16, 95% confidence interval (CI) 0.05 to 0.49; one trial; 96  
 
women). They also tended to need less oxytocin , and were less likely to need  
 
Caesarean sections.  
 
There were 9 trials (1282 women) that compared the use of oral misoprostol to  
 
intravenous oxytocin. Those taking oral Misoprostol had a significantly lower  
 
Caesarean rate. However, they had a higher rate of meconium stained liquor. 
 
 
12 trials (3859 women) compared oral misoprostol to vaginal dinoprostone.  Those  
 
that received oral misoprostol had a lower probability of undergoing caesarean section  
 
(40) . 100 mcgm of oral Misoprostol and 25 mcgm of vaginal Misoprostol have  
 
similar efficacy (41). 
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 Prostaglandin E2  
 
Dinoprostone is a synthetic analogue of PG-E2.  Commercially, it is available as a  
 
time-release insert for vaginal use, a gel and a 10 milligram suppository. The first two  
 
are only indicated in the use of labour induction at term. However, the 10 mg  
 
suppository can be used for second trimester abortions, as well as termination of  
 
pregnancy in case of intrauterine death upto 28 weeks of gestational age (1) . 
 
Local PGE2 is commonly used for cervical ripening (ACOG 2013b). The gel form is  
 
available preloaded in a syringe, which delivers 0.5 mg of Dinoprostone into the  
 
cervix, just below the internal os. This can be repeated 6 hourly, a maximum of three  
 
doses within 24 hours. The patient needs to remain lying down for at least 30 mins  
 
after application. Subsequent use of Oxytocin should be delayed by at least 6 – 12  
 
hours. The 10mg vaginal insert is a thin polymeric wafer which is held within a small  
 
mesh polyester sac which has a long tail attached enabling easy removal from the  
 
vagina. This formulation allows for slower release of the compound – 0.3 mg/hour –  
 
when compared to the gel form. It is placed in the posterior vaginal fornix as a single 
dose.  
 
The woman should then remain recumbent for 2 hours at least. Removal of the insert  
 
should take place after 12 hours, with the onset of labour and at minimum 12 hours  
 
prior to initiating oxytocin. 
 
A Cochrane Review published in 2014 found that PGE2, when compared to placebo/  
 
no treatment, probably reduces the likelihood of not achieving vaginal delivery in 24  
 
hours. The risk of hyperstimulation with FHR changes is increased. The risk for  
 
having a caesarean delivery is probably decreased by about 10%. The various  
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formulations (gels/ pessaries/ tablets) seemed to be equally effective. Differences in  
 
acions appear to be marginal, and may be due to chance (42). 
 
 
 
 Prostaglandin F2Alpha 
 
This compound has also been used for the induction of labour. Though not much  
 
study has been done on the prostaglandin, it has been shown to increase the  
 
probability of achieving vaginal birth. There is an increase in rates of hypertonus, but  
 
this does not seem to translate to higher rates of caesarean section (42). 
 
 
Prostaglandins should be used with caution in women with glaucoma or asthma.  
 
However studies show Dinoprostone may be safe in asthmatics (43).  
 
Manufacturers advise caution when used in women with ruptured membranes, when  
 
cephalopelvic disproportion is suspected, those already on oxytocin, those with history  
 
of 6 or more term pregnancies and those with a contraindication to undergoing vaginal  
 
delivery. 
 
 
 Nitric Oxide donors 
 
Nitric oxide probably mediates cervical ripening (1). Hence, research has been  
 
directed to drugs that can produce this compound (glyceryl trinitrate, isosorbide  
 
mononitrate) and their potential use in induction of labour (44) . Isosorbid mononitrate  
 
also induces COX-2 enzyme in the cervix and causes cervical ripening. However, a  
 
Cochrane review which analysed 10 trials found that nitric oxide donors are not  
 
useful for ripening of the cervix. Further clinical trials are required in this field of  
 
study (45).  
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 Oxytocin 
 
Oxytocin is produced from the hypothalamus and secreted from the posterior part of  
 
the pituitary gland. It is a polypepetide hormone and secreted in a pulsatile form. Its  
 
synthetic analogue is one of the most potent uterotonics known.  
 
It is a known method of induction of labour (46). Administrating exogenous oxytocin  
 
in pregnancy causes uterine contractions, first demonstrable after 20 weeks. Its action  
 
increases as pregnancy advances due to increasing number of myometrial receptors to  
 
the same. 
 
A Cochrane review (46) showed that oxytocin as an induction agent versus expectant  
 
management resulted in more vaginal deliveries, but this was not true when oxytocin  
 
was compared to vaginal prostaglandins. 
 
Its use as an agent of augmentation is preferred in modern Obstetrics. 
 
Mechanical Techniques 
 
 
These include  
 Transcervical placement of Foleys catheter 
 Membrane stripping 
 Hygroscopic agents 
 Amniotomy 
 
These methods have been found to have very low incidences of uterine tachysystole  
 
when compared to prostaglandins. The rate of caesarean section appears to be  
 
unchanged. 
 
 Transcervical Catheter 
 
The use of a catheter to dilate the cervix was first attributed to Barnes in the 1860‟s.  
 
Embrey and Mollison have since been credited with rediscovering its use in 1967 (47).  
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Mechanism of Action: Distension by the catheter causes release of endogenous  
 
Prostaglandins from the amnionic cells, myometrium,etc. (48) . This then causes  
 
cervical ripening. Lim et al found that insertion of a Foleys catheter causes an  
 
inflammatory reaction, and immunohistochemistry of the cervical tissue following  
 
balloon insertion shows significant increase in levels of interleukin-6 and 8,  
 
hyaluronic acid synthetase, metalloproteinase-8 and NO synthetase (49). 
 
 
Two types of catheters are available - one is the Foleys catheter which is most often  
 
used (off-label use), and the other is a commercially available double balloon catheter. 
 
 
 
      Single balloon (eg. Foleys) Catheter        Double Balloon (eg. Cooks) catheter 
  
 
 
The double balloon catheter was developed by Atad in 1990. Simultaneous pressure  
 
against the inner and outer margins of the cervix was postulated to cause better  
 
cervical ripening than the single balloon catheter. This catheter is usually expelled at a  
 
cervical dilatation of 4 cms. 
 
The catheters may be inflated with a volume of 30 to 80ml and kept in situ for a  
 
period of 12 hours. They are not routinely used when membranes have been ruptured,  
although a clinical trial, the FOLCROM study (Foley Catheter in Rupture of  
Membranes) is being undertaken to evaluate its use in prelabour rupture of  
membranes. 
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Risk of Infection: Cochrane review in 2012 (33 trials), concluded that there is no  
increased risk of infection with Foleys catheter. However, in view of limited trials,  
differing criteria for infection and most studies being conducted in the setting of intact  
membranes, this opinion should be interpreted with caution (50). 
A Cochrane review in 2012 compared mechanical induction of labour with various  
 
other methods. The reviewers included 71 randomised trials encompassing 9722  
 
women. 
 
Mechanical methods versus vaginal PGE2:  Overall, there was no significant  
 
difference in the percentage of women who had vaginal delivery in the span of 24  
 
hours.  On subgroup analysis it was found that in multiparous women, the risk of not  
 
achieving delivery at all within twenty four hours was higher. There was no increase  
 
in the rate of caesarean sections. 
 
Mechanical methods versus PGE1/ Intracervical PGE2:  No significant difference in  
 
women not achieving vaginal birth in 24 hours. With mechanical methods, there was a  
 
lower rate of uterine hyperstimulation. With both mechanical methods and  
 
prostaglandins, the risk of caesarean section was comparable between the two groups.  
 
There was no significant difference in rates of severe neonatal/ maternal morbidity  
 
between the two groups (51) . 
 
 
 
 Hygroscopic Cervical Dilators 
 
These devices have osmotic properties, drawing water slowly out of the cervix, thus  
 
causing cervical dilatation. They are of various types- some derived from Lamniaria  
 
algae, others are synthetic eg. Dilapan-S, which is made up from acrylic gel. These  
 
have been in use for over 40 years, especially for termination of pregnancy. Their use  
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for cervical ripening is also known, although there are concerns over ascending  
 
infection, which haven‟t been adequately addressed. There seem to be few advantages,  
 
other than the low cost. They appear to be safe, but anaphylaxis is a rare complication  
 
(52).  
 
 
 Stripping of membranes at term 
 
This procedure can be done on an outpatient basis. It is a procedure by which the  
 
examining health professional inserts their finger into a partially dilated cervix and  
 
partly detaches the lower portion of the membranes in a circumferential fashion. This  
 
probably releases endogenous prostaglandins, and causes the  onset of labour. 
 
A Cochrane review analysed 22 trials (2797 women) that compared membrane  
 
stripping to either no treatment, to prostaglandins, or to oxytocin.  All groups had  
 
similar risk of Caesarean section. Sweeping membranes as a general policy at term led  
 
to shorter duration of pregnancy(gestation) as well as reduced the likelihood of  
 
pregnancies going beyond 41 and 42 weeks of gestation. If one wants to avoid ONE  
 
induction of labour, one needs to sweep membranes in 8 women (number needed to  
 
treat = 8). Thus sweeping of membranes for 8 patients results in at least one of them  
 
going into spontaneous labour. 
 
Rates of maternal/ neonatal infection were similar in the groups. However, studies  
 
wherein sweeping of membranes were compared to Prostaglandins had limited sample  
 
sizes, and did not provide any evident benefit (53). 
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 Amniotomy 
 
Artificial rupture of membranes can be done to both induce as well as augment labour.  
 
When used as a method for induction, there is a rather unpredictable relationship  
 
between time of membrane rupture and onset of labour. This can be hastened by  
 
combining this method with use of oxytocin. Mercer et al randomized patients to  
 
either amniotomy at a dilatation of 1-2 cms with oxytocin, versus amniotomy at 5  
 
cms, and found that early amniotomy and augmentation reduces duration of labour  
 
significantly by 4 hours. However, early amniotomy is associated with an increased  
 
rate of chorioamnionitis (54). 
 
 
Failed Induction 
 
Those who enter labour spontaneously have higher chances of achieving a vaginal  
 
delivery than those who undergo induction of labour. There is no standard definition  
 
of failed induction. The term is used when a woman fails to enter active stage of  
 
labour after 12 hours of augmentation, with adequate uterine contractions. ACOG in  
 
2012 has proposed that failed induction should be defined as failure to generate  
 
regular contractions approximately every three minutes and cervical change after at  
 
least 24 hours of oxytocin administration (55). Cervical ripening may take place prior  
 
to oxytocin administration, with one or several doses of prostaglandins. This may  
 
extend over 1-2 days, and this time period is not included when considering failed  
 
induction.  
 
This new definition was proposed at a workshop help in the United States in 2012 –  
 
Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver  
 
National Institute of Child Health and Human Development, Society for Maternal- 
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Fetal Medicine, and American College of Obstetricians and Gynecologists Workshop. 
 
Once patients who are induced enter into active labour, duration of active labour is  
 
similar to, if not faster, than women who come in spontaneous labour. Duration of  
 
second stage does not differ among the two groups (56). 
 
A key point made at the workshop was that induction of labour should always be  
 
performed primarily for a medical indication. If done for non medical indications, the  
 
patient should be a minimum of 39 weeks gestational age and the cervix must be  
 
favourable, more so in nulliparous women. 
 
 
Misoprostol And Foleys- Current Knowledge 
 
Decreasing the rate of primary caesareans has always been a priority. The technique of  
 
combining Misoprostol and Foleys for induction of labour may have additive effect in  
 
the induction of labour, since both have different mechanisms of action. If this is true,  
 
it may lead to shorter induction to delivery intervals, and more chances of achieving a  
 
vaginal delivery.  
 
 
Rust et al randomized singleton patients with an indication for delivery, those with an  
 
unfavourable Bishops score (<5) and no contraindication to vaginal delivery were  
 
randomly assigned to two groups – vaginal PGE1 25 mcgms every 3 hours, and  
 
intracervical Foleys catheter inflated with 50 ml sterile water plus the same dosage of  
 
PGE1. Over the period of 1 year, 81 patients were randomized, 40 to PGE1 alone, and  
 
41 to Foleys + PGE1. 
 
They concluded that maternal and Fetal outcomes, induction to delivery intervals and  
 
caesarean section rates did not differ between the two groups (57). 
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Lanka et al conducted a similar study in women >28 weeks with an indication for  
 
induction of labour, with a singleton pregnancy in cephalic presentation, Bishops  
 
score <4 with intact membranes and randomized them into two groups- Foleys +  
 
Misoprostol versus only Misoprostol. They recruited 128 women over a period of 2  
 
years.  
 
Their study showed no significant difference between the two groups with  
 
regard to either induction to delivery interval or rate of caesarean sections.  
 
The rate of meconium stained liquor was higher in the misoprostol group (58). 
 
Chung et al conducted a similar trial, with three arms- Misoprostol alone, Foleys alone  
 
or a combination of the two for the induction of labour. They included singleton  
 
pregnancies >= 28 weeks, with a bishops score of <=6. 
 
A total of 146 patients were recruited, out of which 49 received Misoprostol, 54  
 
received Foleys catheter and 43 patients a combination of both. They found no  
 
difference in the rate of vaginal delivery in the three groups (misoprostol, 63.3%;  
 
Foley, 57.4%; combination, 58.1%; P=.81). There also was no difference in induction  
 
to active phase intervals or induction to delivery intervals between the three   
 
groups(59). 
 
Since the previous studies showed inconsistent results, Chen et al (16) did a meta- 
 
analysis of a total of 8 trials and 1153 patients.The studies included in this analysis  
 
were all randomized control trials on pregnant women induced with Foleys and  
 
Misoprostol with Foleys versus Misoprostol alone. 
 
Meta-analysis of Chen et al: 
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Inclusion criteria 
---------------------------- 
      F+M group,Route + Dose                 
--------------------------------------- 
Study 
 
 
Gestation 
 
Bishops 
score       
       
 
M group 
Route + Dose 
------------------- 
    F+M           M 
Number of 
patients 
--------------------- 
Lanka et 
al. 2014  ≥ 28 ≤ 4 
16 F,30 
mL 
Vaginal,25 μg 
every 4 h 
Vaginal, 25 μg 
every 4 h 63   63 
 
Ugwu et 
al. 2013  ≥ 37 ≤ 5 
16 F, 30 
mL 
Vaginal<comma> 
25 μg every 4 h 
Vaginal, 25 μg 
every 4 h 40 40 
 
 
 
Carbone et 
al. 2013  
 
 
 
≥ 24 
 
 
 
≤ 6 
 
 
 
unknown 
size,60 
mL 
 
 
 
Vaginal,25 μg 
every 4 h 
 
 
 
Vaginal, 25 μg 
every 4 h 
 
 
 
56 
 
 
 
61 
Hill et al. 
2009  24–42 ≤ 4 
24 F, 50 
mL 
Oral, 100 μg at 
4–6 h intervals 
Vaginal, first dose 
50 μg,then 25 μg 
at 3–6 h intervals 106 126 
 
Kashanian 
et al. 2006  ≥ 28 ≤ 5 
16 F,30 
mL 
Vaginal, 25 μg 
every 3 h 
Vaginal,25 μg 
every 3 h 100 100 
 
Chung et 
al. 2003  ≥ 28 ≤ 6 
16 F, 30 
ml 
Vaginal, 25 μg 
every 3 h 
Vaginal, 25 μg 
every 3 h 43 49 
 
Barrilleaux 
et al. 2002 
  
Not 
provided 
 
≤ 7 
 
24 F,50 
mL 
 
Oral, 100 μg 
every 4 h 
 
Oral, 100 μg every 
4 h 
 
109 
 116 
Rust et al. 
2001  Term ≤ 7 
24 F, 50 
mL 
Vaginal,25 μg 
every 3 hours 
Vaginal, 25 μg 
every 3 hours 41 40 
 
 
 
Results: 
 
Induction to delivery interval: The combination group (F+M) was found to have a  
 
shorter mean time to delivery than the Misoprostol alone (M), but the difference was  
 
not of statistical significance (mean difference –1.46 hours, 95% CI –3.72 to 0.81;  
 
P = 0.21). The heterogeneity between all the studies, was however, significant. 
 
 
Caesarean Delivery: The rates of Caesarean were similar in both groups. 
 
 
Chorioamnionitis: Most studies either did not report on chorioamnionitis or else had  
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inconsistent definitions for the same. Of the 666 patients eligible for analysis, there  
 
was a significant increase in the risk for chorioamnionitis in the combination group. 
 
 
Uterine tachysystole with Fetal Heart Rate changes: 5 studies reported on this  
 
outcome, and the combination group had a significantly decreased incidence of the  
 
same.  
 
 
Others: There were no significant differences in the two groups for the other  
 
outcomes- endomyometritis, oxytocin augmentation, meconium stained amniotic fluid  
 
or NICU admission. 
 
 
This review found that using a combination of Foleys and Misoprostol for induction  
 
of labour resulted in a shorter induction to delivery interval, less hyperstimulation and  
 
higher incidence of chorioamnionitis when compared to use of Misoprostol alone.  
 
However the studies were heterogenous, using varying definitions and regimes for  
 
induction. They were not double blinded due to inherent study design. The conclusion  
 
that chorioamnionitis is higher in the combination group should be interpreted with  
 
caution due to the few numbers of patients eligible for inclusion in this regard. The  
 
authors concluded that more studies are needed to evaluate the efficacy and safety of  
 
using these methods of cervical ripening for induction of labour. 
 
 
Hence we endeavored to retest this hypothesis by conducting an adequately powered  
 
randomized quality study. 
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METHODOLOGY 
 
This is a prospective, randomised control trial to study the efficacy of Foleys 
and Misoprostol versus Misoprostol alone for induction of labour. 
The trial was presented before the Institutional Review Board in Christian Medical  
College, and protocol was approved prior to start of recruitment. All Primigravida,  
low risk, term patients coming to CMC labor room & Obstetrics wards for routine  
induction of labor were screened for the trial.  All primigrravidas with singleton  
pregnancies  in longitudinal lie and cephalic presentation at 37 +0 to 40+6 weeks of  
gestation, with a medical indication for induction, intact membranes and a Bishops  
score of <6 were counselled for participation in this trial.  High risk pregnancies,  
multigravidas, non vertex pregnancies, those with fever/ sepsis, those undergoing  
reinduction or those with a known allergy to Misoprostol/ Latex were excluded. 
Eligible women who agreed to be part of the trial, were given an information  
sheet and explained about details of the trial. If they agreed, they were asked to sign a  
consent form.  
Inclusion Criteria  
 Primigravida 
 37 completed weeks to 40+6 weeks of gestation 
 Low risk pregnancy 
 Singleton, cephalic presentation, live fetus 
 Intact membranes 
 Bishops Score <6 (not in labour) 
 Reactuve preinduction CTG 
Exclusion Criteris 
 Multigravida 
 Bishops Score >8 
 High Risk Pregnancy 
 Rupture of membranes 
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 Maternal fever 
 Non vertex presentation 
 Non reassuring CTG 
 Reinduction (previously unsuccessful induction of labour) 
 Allergy to Misoprostol/ latex 
Patients were recruited from July 2015 to August 2016 in Christian Medical College, a  
2450 bed, tertiary care, teaching hospital. 
Consenting women were then subjected to a pre induction Non Stress Test, which was  
carried out for a minimum of 20 minutes. If this was reactive, the Principal  
Investigator was called in to randomise the patient. 
Patients were randomly allotted to two groups – those for induction with Misoprostol  
plus Foleys catheter and those for induction with only Misoprotol – using computer  
generated randomisation codes in a 1:1 ratio using Block randomisation. Permuted  
 
Block randomization of various proportions with block sizes of 2,4 or 6 were  applied  
 
and random sequence was generated. SAS 9.1.3 was used to generate the sequence. 
 
Sealed, opaque envelopes were used, and the Principle Investigator was not aware of  
the randomisation sequence prior to actual randomisation. 
However, due to the nature of treatment, after randomization, the patient, principal  
investigator & caregiver were aware of the arm into which the patient was allocated. 
Patients in the combination arm were induced with a 16 Fr Foleys catheter inserted by  
registrars into the cervix and inflated with 30ml of distilled water.  Simultaneously, 25  
mcgm of Misoprostol was inserted into the posterior fornix of vagina, which was  
repeated 4 hourly for a total of 3 doses with Foleys in situ.  Foleys was removed  
after 12 hrs of insertion, unless there was an indication to do so earlier. Patients  
were monitored with continuous CTG. Subsequent doses of Misoprostol were  
withheld if patient developed contractions, ruptured of membranes or fetal heart 
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 became non reassuring . 
Patients in the Misoprostol Only arm were induced with Misoprostol alone, 25 mcgm  
Q4th hourly for a total of 3 doses in the posterior fornix of vagina by registrars.  
Continuous CTG monitoring was done. Indications for abandoning subsequent doses  
were similar as in the combined treatment arm. 
Baseline data was collected for these patients at recruitment, which included Body  
Mass Index, Age, Socioeconomic status. Additional information was collected after  
delivery, such as induction to delivery interval, data pertaining to the neonate, details  
of vaginal delivery, instrumental delivery and caesarean section. Failed induction was  
defined as failure to enter into the active stage of labour after 12 hours of   
augmentation with Oxytocin, with adequate uterine contractions. 
 
Sample Size calculation: The required sample size to show that there is at least two  
and a half hours difference in the induction to delivery between the groups receiving  
misoprostol alone and the combination of misoprostol and foleys with 80% power and  
5% level of significance was found to be 305 women in each arm. The sample size  
was calculated on the basis of taking average standard deviation from both groups as  
11 as demonstrated by Chung et al (59) 
 
 
 
Two Means - Hypothesis 
testing for two means 
 
 
Standard deviation in group  
Misoprostol alone 
11 
Standard deviation in group  
Misoprostol + Foley 
11 
Mean difference 2.5 
Effect size 0.227273 
Alpha error (%) 5 
Power (1- beta) % 80 
1 or 2 sided 2 
Required sample size per group 304 
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Statistical Analysis: 
Table 
                    Inclusion Criteria 
1. Primigravida 
 
2. 37 completed weeks to 40+6 weeks gestational age 
 
3. Low risk pregnancy 
 
4. Singleton, cephalic presentation, live fetus 
 
5. Intact membranes 
 
6.             Bishop score < 6(not in labor) 
 
7. Reactive pre induction CTG 
 
 
Table 
          Exclusion Criteria 
1. Multi gravid 
 
2. Bishops score >8 
 
3. High Risk Pregnancy 
 
4. Rupture of membranes 
 
5. Maternal fever 
 
6.            Non vertex presentation 
 
7.            Non reassuring CTG 
 
8. Reinduction (previously unsuccessful induction of labour) 
 
9. Allergy to misoprostol/latex 
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RESULTS 
A total of 14,957 patients were admitted to the CMC Labour room from 1
st
 August  
2015 to 31
st
 July 2016, of which 5,604 were admitted for induction of labour. 
According to the convenience of the principal investigator approximately 1000 
patients were screened. Of which 300 patients were randomized after fulfilling the 
inclusion and exclusion criteria. Remaining patients were excluded as they were 
multiparous, preterm in gestation not willing for participation in trial or had high risk 
factors such as pre-eclampsia.  
A total of 300 patients were recruited into the study. Of these, 151 patients were 
induced with Misoprostol only and 149 patients were induced with Misoprostol and 
Foleys catheter. 
The baseline characteristics are shown in Table 3. The groups were similar in age, 
except for the age group of >30 years, which had more patients randomised to the 
Misoprostol and Foleys group. 172 patients (57.3%) were from Vellore, 70 patients 
(23.3%) were from the rest of Tamil Nadu and 58 patients (19.3%) from outside Tamil 
Nadu. There were about 49.7% patients with a BMI of >25 kg/m2 in the Misoprostol 
arm, and 39.6% in the Misoprostol and Foleys arm. 41 patients (27.3%) had anemia, 
and 36 patients (12%) had primary infertility. The group randomised to the 
Misoprostol arm had 85 patients (55.6%) with a Bishops score of < 3 and 66 patients 
(43.7%) with a Bishops score of >3, but in the Misoprostol and Foleys group, there 
were more patients with Bishops score of <3 (79.2%) compared with Bishops score 
>3 (20.8%). 
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Patient Flow Chart 
5,604 
Number of Patients admitted to  
CMC labour room  
for induction of labour between 
 1
st
 August 2015 to 31
st
 July 2016. 
 
 
 
Of 5,604 patients approximately 1000  
Patients screened for eligibility          
 
700 Patients Excluded 
 Multiparous 
 Preterm Gestation 
 High Risk pregnancies 
 Ruptured Membranes 
 Not willing to participate 
 
 
300 Patients enrolled 
And analysed 
 
 
 
Misoprostol Only Arm                                                        Misoprostol and Foleys Arm    
(n=151)                                                                                        (n= 149) 
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BASELINE CHARACTERISTICS 
Table No. 1 
 
BASELINE CHARACTERISTICS 
 
DEMOGRAPHIC DATA Misoprostol 
alone 
Misoprostol and 
Foleys 
Total 
1. Age(years) 
 <18 
 19-30 
 >30 
 
13(8.6%) 
131(86.8%) 
7(4.6%) 
 
12(8.1%) 
125(83.9%) 
12(8.1%) 
 
25(8.3%) 
256(85.3%) 
19(6.3%) 
2. Hometown 
 Vellore 
 Rest of Tamil Nadu 
 Outside Tamil 
Nadu 
 
 
91(60.3%) 
35(23.2%) 
25(16.6%) 
 
81(54.4%) 
35(23.5%) 
33(22.1%) 
 
172(57.3%) 
70(23.3%) 
58(19.3%) 
3. BMI 
 <18.5 
 19.5-24.9 
 25-29.9 
 30> 
 
4(2.6%) 
72(47.7%) 
61(40.4%) 
14(9.3%) 
 
2(1.3%) 
88(59.1%) 
45(30.2%) 
14(9.4%) 
 
6(2.0%) 
160(53.3%) 
106(35.3%) 
28(9.3%) 
 
4. ANTENATAL RISK 
FACTORS 
   
Primary infertility 22(14.6%) 14(9.4%) 36(12.0%) 
Elderly 10(6.6%) 14(9.4%) 24(8.0%) 
Anemia 24(15.9%) 17(11.4%) 41(13.7%) 
5. BISHOPS SCORE AT 
INDUCTION 
 2 & 3 
 4,5,6 
 
 
 
85(55.6%) 
66(43.7%) 
 
 
 
118(79.2%) 
31(20.8%) 
 
 
 
203(67.3%) 
97(32.3%) 
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Graph 1- AGE WISE DISTRIBUTION (%) 
 
 
Graph 2- Domicile Status 
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Graph 3 – BODY MASS INDEX 
 
Risk Factors – High risk patients were excluded from the study. There were more 
patients with Primary Infertility in the Misoprostol only arm (22 versus 14), more 
patients with anemia in the Misoprostol only arm (24 versus 17), and more elderly 
patients in the Misoprostol and Foleys arm (14 versus 10). 
GRAPH 4 – MATERNAL RISK FACTORS 
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Bishops Score at induction- There were more patients with a Bishops score of 2 or 3 
randomised to the Misoprostol and Foleys arm compared to the Misoprostol only arm 
(118 versus 85).  Those with a higher Bishops score (4,5 or 6) were randomised in 
larger numbers to the Misoprostol only arm (66 versus 31 patients). 
 
Graph 4 – BISHOPS SCORE AT INDUCTION 
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OUTCOME MEASURES 
Primary Outcomes 
There was a shorter induction to delivery interval in the Misoprostol only arm by 1 
hour 18 minutes compared to the Misoprostol and Foleys arm. This difference was 
statistically significant (p value 0.017). The latent phase of labour was found to be 
shorter by 1 hour and 16 minutes in the Misprostol only group (p value 0.001). The 
active phase of labour was also shorter in the Misoprostol only group by 44 minutes. 
Though this was not statistically significant (p value – 0.38), this is of clinical 
importance. Shortened active phase of labour may help reduce infectious morbidity, 
the strain on the mother and the baby, as well as allow greater turnover in institutes 
where patient load is greater and doctors are hard pressed for empty beds. 
 
Table No. 2 – Induction to Delivery interval  
Outcome Measures Misoprostol 
Only Arm 
Misoprostol and 
Foleys Arm 
‘p’value 
Induction to Delivery 
Interval (hours) 
Latent phase of labour 
(hours) 
 
Active phase of labour 
(hours) 
18.35 
 
10.16 
 
 
7.08 
19.53 
 
11.02 
 
 
7.52 
0.017 
 
0.001 
 
 
0.386 
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Graph 5 – Induction to Delivery interval                       .
 
Gestational Age and Bishops Score 
The following table shows randomisation in the two groups according to Gestational 
Age and Bishops Score. 
Table No. 3 - Gestational age and bishop score  
Gestational Age 
 
Misoprostol 
Only Arm 
(%) 
Misoprostol 
and Foleys 
Arm (%) 
Total (%) 
1. 37 +0/7 to  
38 + 6/7 weeks 
 
- For Bishops 
score -2 &3 
 
- For Bishops 
Score 4,5,6 
 
 
 
2(66.7) 
 
 
1(33.3) 
 
 
 
3(42.9) 
 
 
4(57.1) 
 
 
5(50%) 
 
 
5(50%) 
 
2 For 39 +0/7 to 
41 +0/7 weeks 
 
- For Bishops 
score -2 &3 
 
- For Bishops 
Score 4,5,6 
 
 
 
 
83(56.1) 
 
 
65(43.9) 
 
 
 
115(81) 
 
 
27(19) 
 
 
 
198(68.3) 
 
 
92(31.7) 
 
0
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induction to 
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Bishops score and duration of labor in each arm  
When patients with Bishops Score of 2 or 3 were randomised, there were a higher 
number of patients randomised to the Misoprostol and Foleys arm (118 patients), as 
compared to the Misoprostol only arm (85 patients). In the combination arm, patients 
were in the latent phase of labour for 30 minutes longer than those randomised to the 
Misoprostol only arm.  Corrected values showed a difference of 30 minutes between 
both arms, with a „p‟ value of 0.35 Given the theoretical synergistic benefit of adding 
Misoprostol to Foleys induction, one would have expected these patients to have a 
shorter latent phase. 
 
Table No. 4 - Bishops score and duration of labor in each arm. 
 
 
Randomisation Arm 
Latent 
Phase(hours) 
Active 
Phase(hours) 
Total 
Duration(hours) 
Misoprostol 
 
- For Bishops 
score -2 &3 
 
- For Bishops 
Score 4,5,6 
 
 
11.20 
 
 
9.32 
 
 
 
 
7.48 
 
 
6.55 
 
 
19.49 
 
 
16.88 
Misoprostol with Foleys 
 
- For Bishops 
score -2 &3 
 
- For Bishops 
Score 4,5,6 
 
 
 
11.22 
 
 
10.27 
 
7.62 
 
 
7.13 
 
 
20.08 
 
 
17.46 
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SECONDARY OUTCOMES 
Mode of Delivery 
111 of the patients in the Misoprostol only arm had a vaginal delivery, of which 40 
required instrumentation. In the Misoprostol and Foleys arm, 106 had a vaginal 
delivery, of which 51 required instrumentation. The LSCS rate was similar in both 
arms – 26.5% in the Misoprostol only arm and 28.9% in the Misoprostol and Foleys 
arm.  
Table No. 5 – Mode of Delivery 
Mode of Delivery Misoprostol 
Only Arm 
Misoprostol and 
Foleys Arm 
Total ‘p’value 
Spontaneous Vaginal 
Delivery  
-normal 
-instrumental 
-lscs 
 
 
 
Caesarean Section 
 
Indications 
- NRFS 
- Arrest Disorder/ 
CPD 
- Failed Induction 
 
 
 
71(47.0%) 
40(26.5%) 
40(26.5%) 
 
 
 
 
 
 
18(11.9%) 
 
8(5.3%) 
16(10.6%) 
 
 
55(36.9%) 
51(34.2%) 
43(28.9%) 
 
 
 
 
 
 
22(14.8%) 
 
8(5.4%) 
11(7.4%) 
 
 
126(42.0%) 
91(30.3%) 
83(27.7%) 
 
 
 
 
 
 
40(13.3%) 
 
16(5.3%) 
27(9.0%) 
 
 
 
0.178 
 
 
 
 
 
 
 
 
 
 
0.725 
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Graph 6 – Mode of Delivery 
 
Majority of the Caesarean Sections were done for NRFS. Other indications were arrest 
disorders/ CPD and Failed induction. 
 
Graph 7 – Indications for LSCS 
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Epidural Use 
Epidural use was a potential confounding factor as its use is known to prolong labour. 
Epidural use was found to be similar in both groups. 
Table 6 –Epidural Use 
 Misoprostol 
Only Arm 
Misoprostol and 
Foleys Arm 
Total ‘p’value 
 
Epidural Use 
 
 
 
17(11.3%) 
 
 
16(10.7%) 
 
 
33(11.0%) 
 
 
0.886 
 
 
 
Meconium stained amniotic fluid 
More patients in the Misoprostol only arm had meconium stained fluid compared to 
those in the Misoprostol and Foleys arm (40- 28.5% versus 14 – 10%). These findings 
are statistically significant, with a p value of 0.001%. Of those in the Misoprostol arm, 
19.9% had thin meconium and 6.6% had thick meconium. In the Misoprostol and 
Foleys arm, 8.7% had thin meconium and 1.3% had thick meconium. 
Table 7 – Meconium Stained Liqour 
 Misoprostol 
Only Arm 
Misoprostol and 
Foleys Arm 
Total ‘p’value 
Meconium Stained Liqour 
- Thin Meconium 
- Thick Meconium 
 
 
 
30(19.9%) 
10(6.6%) 
 
 
13(8.7%)  
2(1.3%) 
 
 
43(14.3%) 
12(4.0%) 
 
 
0.001 
 
 
 
There were a higher number of Caesareans and Instrumental deliveries in those 
pregnancies complicated by meconium stained liquor. Of all the patients with 
meconium staining, 40 were in the Misoprostol Arm. 25 of these patients underwent 
LSCS/ Instrumental deliveries whereas15 underwent spontaneous vaginal delivery.  
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There were fifteen patients in the Misoprostol and Foleys arm with meconium 
staining. 14 of these underwent LSCS/ Instrumental deliveries and only 1 patient had a 
spontaneous vaginal delivery. 
Table 8 – Meconium stained Liqour and Mode of Delivery 
Meconium stained 
liquor 
Mode of delivery 
Normal       Instrumental       LSCS         
Total ‘p’ value 
Misoprostol arm 
 
Thin msaf 
Thick msaf 
 
 
 
 
14(19.7%) 
1(1.4%) 
 
 
 
7(17.5%) 
4(10.0%) 
 
 
 
9(22.5%) 
5(12.5%) 
 
 
 
30(19.9%) 
10(6.6%) 
 
 
 
 
0.157 
Misoprostol with Foleys 
arm 
 
Thin msaf 
Thick msaf 
 
 
 
 
1(1.8%) 
0(0.0%) 
 
 
 
 
 
5(9.8%) 
2(3.9%) 
 
 
 
 
 
7(16.3%) 
0(0.0%) 
 
 
 
 
13(8.7%) 
2(1.3%) 
 
 
 
 
 
0.034 
 
Hyper- stimulation warranting use of Terbutaline 
More patients in the Misoprostol only arm had hyperstimulation requiring the use of 
Terbutaline compared to those in the Misoprostol and Foleys arm (21 patients- 13.9% 
versus 15 patients - 10.1%). This difference was not statisitically significant. 
Table 9 – Hyperstimulation warranting use of terbutaline 
 Misoprostol 
Only Arm 
Misoprostol and 
Foleys Arm 
Total ‘p’  value 
Hyper- stimulation 
warranting use of 
Terbutaline 
-yes 
-no 
 
 
 
 
21(13.9%) 
130(86.1%) 
 
 
15(10.1%) 
134(89.9%) 
 
 
36(12.0%) 
264(88.0%) 
 
 
0.306 
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Hyperstimulation and mode of delivery 
The higher rate of hyperstimulation in the Misoprostol only group is reflected in a 
higher rate of Caesarean Section rates in this group compared to Misoprostol and 
Foleys arm (35% versus 18.6%).  This difference was statistically significant. 
Table 10 - Hyperstimulation and mode of delivery 
Hyperstimulation – 
terbutaline use 
Mode of delivery 
normal        instrumental    LSCS 
Total ‘p’  value 
 
Misoprostol arm 
 
 
4(5.6%) 
 
 
 
3(7.5%) 
 
 
14(35.0%) 
 
 
 
21(13.9%) 
 
 
 
<0.001 
 
 
Misoprostol with Foleys 
arm 
 
 
 
 
 
3(5.5%) 
 
 
 
 
4(7.8%) 
 
 
 
 
8(18.6%) 
 
 
 
 
15(10.1%) 
 
 
 
0.081 
 
Incidence of Chorioamnionitis 
The incidence of chorioamnionitis did not differ markedly in the two groups. 
Table 11- Incidence of chorioamnionitis 
 Misoprostol 
Only Arm 
Misoprostol and 
Foleys Arm 
Total ‘p‘  value 
Incidence of 
Chorioamnionitis 
-yes 
-no 
 
 
 
7(4.6%) 
144(95.4) 
 
9(6.0%) 
140(94.0%) 
 
16(5.3%) 
284(94.7%) 
 
0.588 
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Post Partum Haemorrhage  
There were 12 patients in the Misoprostol only group with post partum haemorrhage 
compared to 13 patients in the Misoprostol and Foleys group, this difference was not 
significant. 
 
Table 12 – Post Partum Haemorrhage 
 Misoprostol 
Only Arm 
Misoprostol and 
Foleys Arm 
Total  ‘p’ value 
Atonic PPH 
 
12(7.9) 13(8.7) 25(8.3) 0.886 
 
Post partum complications – Maternal 
The incidence of endomyometritis was higher in the Misoprostol arm compared to 
Misoprostol and Foleys (9 patients, 6% versus 4 patients, 2.7%). Wound infection was 
slightly higher in the Misoprostol and Foleys arm – 12 patients, 4% compared to 
Misoprostol only arm – 4 patients, 2.6%.  Neither of these findings was statistically 
significant. One patient in the Misoprostol and Foleys arm developed pneumonia. UTI 
occurred in both groups in equal measure. 
Table 13 - Post Partum Complications in the mother 
 Misoprostol 
Only Arm 
Misoprostol 
and Foleys Arm 
‘p’value Total 
Puerperal Fever 
- UTI 
- Endomyometritis 
- none 
- Wound infection 
(LSCS/ Episiotomy) 
- Pneumonia 
 
 
 
5(3.3%) 
9(6.0%) 
133(88.1%) 
 
4(2.6%) 
0(0.0%) 
 
6(4.0%) 
4(2.7%) 
130(87.2%) 
 
8(5.4%) 
1(0.1%) 
 
11(3.7%) 
13(4.3%) 
263(87.7%) 
 
12(4.0%) 
1(0.3%) 
 
0.358 
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Obesity affecting the duration of labour 
For a BMI of 18.5 to 24.9 kg/m2, there was no statistically significant difference 
between the two groups. There was 58 minutes reduction in the duration of the latent 
phase in the Misoprostol only group as compared to the Misoprostol and Foleys 
group. Active phase was also shorter in the Misoprostol only group by 22 minutes. 
Table 14 - BMI – 18.5 – 24.9 kg/m2:  
 
Randomisation Arm 
Latent 
Phase(hours) 
Active 
Phase(hours) 
Total 
Duration(hours) 
Misoprostol 
 
 
 
10.29 
 
7.36 18.48 
Misoprostol with Foleys 
 
 
 
 
11.27 8.28 19.33 
P value 0.15 0.290 0.668 
 
 
 
 
For a BMI of 25 to 29.9 kg/m2, there was a statistically significant difference between 
both the latent and the active phase of labour, both being significantly shorter in the 
Misoprostol only arm. The latent phase was shorter by 1 hour 51 minutes (p value 
0.001) and the active phase by 35 minutes (p value 0.002). The total duration of labour 
was thus reduced by 2 hours 39 minutes in the Misoprostol only group. 
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Table 15 - BMI – 25- 29.9 kg/m2 
 
Randomisation Arm 
Latent Phase(hours) Active Phase(hours) Total Duration(hours) 
Misoprostol 
 
 
 
10.25 7.35 18.32 
Misoprostol with Foleys 
 
 
 
 
11.36 7.30 20.31 
P value 0.001 0.002 0.369 
 
For a BMI of >30, there was a reduction in the duration of the latent phase by 37 
minutes and active phase  by 28 minutes for the Misoprostol only group. The overall 
duration of labour was 2 hours and 16 minutes less than the Misoprostol and Foleys 
group. However, this difference was not statistically significant. 
Table 16 – BMI >30 kg/m2 
 
Randomisation Arm 
Latent 
Phase(hours) 
Active 
Phase(hours) 
Total 
Duration(hours) 
Misoprostol 
 
 
 
11.19 6.18 20.19 
Misoprostol with Foleys 
 
 
 
 
11.22 6.30 18.03 
P value 0.401 0.210 0.734 
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SECONDARY OUTCOMES – NEONATAL 
There were 4 babies with a low Apgar (<5,7) in the Misoprostol only arm, and only 1 
baby with low Apgar in the Misoprostol and Foleys group. This was not statistically 
significant.  Neonatal ICU admission rate was almost identicial in the two groups. 
More babies in the Misoprostol group (27 babies, 17.9%) were diagnosed with 
neonatal sepsis compared to the Misoprostol and Foleys arm (20 babies, 13.4%). 
Table 17 – Neonatal outcomes 
Outcome Measure Misoprostol 
Only Arm 
Misoprostol and 
Foleys Arm 
‘p’value Total 
APGAR score 
- >5,7 
- <5,7 
 
 
147(97.4%) 
4(2.6%) 
 
148(99.3%) 
1(0.7%) 
 
295(98.3%) 
5(1.7%) 
 
0.181 
NICU Admission 
-yes 
-no 
 
10(6.6%) 
141(93.4%) 
 
9(6.0%) 
140(94.0%) 
 
19(6.3%) 
281(93.7%) 
 
0.836 
Neonatal Sepsis 
- Culture Proven 
- Probable Sepsis 
- No sepsis 
 
6(4.0%) 
21(13.9%) 
124(82.1%) 
 
 
2(1.3%) 
18(12.1%) 
129(86.6%) 
 
8(2.7%) 
39(13.0%) 
253(84.3%) 
 
0.314 
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DISCUSSION 
 
This study recruited 300 patients over the period of 1 year from July 2015 to August 
2016.  Of these patients, 151 were recruited to the Misoprostol arm and 149 patients to 
the Misoprostol and Foleys Arm. Only Primigravidas with low risk pregnancies were 
eligible for this trial. 
The baseline characteristics of our two groups were similar with regard to age, BMI 
and risk factors such as anemia and advanced maternal age. There were more patients 
with primary infertility in the Misoprostol only arm, however this is unlikely to have 
bearing on the results. Majority of our patients were from Vellore. 
Majority of our patients were in the BMI range of 19.5 to 24.9 kg/m2: 72 patients 
(47.7%) in the Misoprostol only arm and 88 patients (59.1%) in the Misoprostol and 
Foleys arm. There were 61 patients (40.4%) in the Misoprostol arm and 45 patients 
(30.2%) in the Misoprostol and Foleys arm in the BMI range of 25 – 29.9. 20.3% of 
patients had a BMI of <18.5kg/m2. And 28 patients (9.3%) had a BMI of >30kg/m2. 
We hypothesized that combining Misoprostol and Foleys catheter for induction of 
labour, through their synergistic effect, would shorten induction to delivery interval 
and the overall duration of labour.  
 
Our findings are contrary to this hypothesis. 
There was a shorter induction to delivery interval in the Misoprostol only arm by 1 
hour 18 minutes compared to the Misoprostol and Foleys arm. This difference was 
statistically significant (p value 0.017). The latent phase of labour was found to be 
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shorter by 1 hour and 16 minutes in the Misprostol only group (p value 0.001). The 
active phase of labour was also shorter in the Misoprostol only group by 44 minutes. 
Though this was not statistically significant (p value – 0.38), this is of clinical 
importance. Shortened active phase of labour may help reduce infectious morbidity, 
the strain on the mother and the baby, as well as allow greater turnover in institutes 
where patient load is greater and doctors are hard pressed for empty beds.  
Rust et al, Lanka et a and Chung et al , in similar trials, found no difference in 
induction to delivery intervals between the two groups. These trials had smaller 
sample size (81, 128 and 146 respectively). . Chen et al (16) in the meta analysis of 8 
trials and 1153 patients, found that the combination group had a shorter induction to 
delivery interval by 1hour 46 minutes than the Misoprostol only group, which was not 
statistically significant (p value 0.21).  Our findings are contrary to this, may be 
because our sample size is smaller (300 patients), and target sample size is yet to be 
reached. 
There were more patients with a Bishops score of 2 or 3 randomised to the 
Misoprostol and Foleys arm compared to the Misoprostol only arm (118 versus 85).  
Those with a higher Bishops score (4,5 or 6) were randomised in larger numbers to the 
Misoprostol only arm (66 versus 31 patients). 
Gestational age wise, for patients from 37+0/7 to 38+6/7 weeks, there were 5 patients 
each with a Bishops score of 2/3 and 4/5/6. Of the Bishops score of 2 or 3, two 
patients were in the Misoprostol arm and 3 patients were in the Misoprostol and 
Foleys arm. Of a Bishops score of 4,5 or 6; there was one patient in the Misoprsotol 
arm and 4 patients in the Misoprostol and Foleys arm. Above 39 weeks to 41+0/7 
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weeks, there were 198 patients  (68.3%) with Bishops score of 2 and 3 compared to 92 
patients (31.7%) with a Bishops score score  
Inspite of randomisation of the sample, only 85 patients (55.6%) with a Bishops score 
of 2 and 3 were in the Misoprostol arm. In contrast, there were 118 patients (79.2%) 
with a Bishops Score of 2 and 3 in the Misoprostol and Foleys arm. Despite this 
uneven distribution, it was found that those patients with a lower Bishops score in the 
Misoprostol only arm had a significantly shorter latent phase of labour (30 minutes, p 
value 0.35). As stated earlier, Chen et al in his metanalysis found that combination 
arm reduced the overall duration of labour, although relation to the Bishops score is 
unknown. 
There were more patients with meconium stained liquor in the Misoprostol only arm 
(40 patients, 26.5%) compared to the Misoprostol and Foleys arm (15 patients, 9.4%). 
These findings were statitistically significant (p value 0.001). Although the rates of 
meconium staining were higher in the mata analysis done by Chen et al, this was not 
statistically significant. Lanka et al found a higher rate of meconium staining in the 
Misoprostol group. 
 More patients with meconium stained liquor ultimately underwent Caesarean 
sections/ Instrumental deliveries.  Of the 40 patients in the Misoprostol arm with 
meconium staining, 21.2% underwent normal vaginal delivery, whereas 62.5% had 
either Instrumental/ Caesarean delivery. These findings were statistically significant, 
with a p value of 0.157. Of the 15 patients with meconium stained liquor in the 
Misoprostol and Foleys arm, only one patient had a normal vaginal delivery whereas 
14 patients underwent either Instrumental or LSCS deliveries. These findings were 
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also statistically significant (p value 0.034). Other studies (Lanka et al, Rust et al, 
Chen et al) did not find a statistically significant difference in the rates of Vaginal/ 
Instrumental/ Caesarean deliveries in the two groups. 
21 patients (13.9%) in the Misoprostol arm required Inj. Terbutaline for 
hyperstimulation as compared to 15 patients (10.1%) in the Misoprostol and Foleys  
arm. However, this difference was not found to be statistically significant (p value 
0.3). Cheng et al  analysed 5 trials that studied this outcome and found the the 
combination group had a significantly decreased incidence of tachysystole. 
Women in the BMI range of 25 to 29.9 kg/m2 had a statistically significant reduction 
in  both the latent and the active phase of labour, both being significantly shorter in 
the Misoprostol only arm. The latent phase was shorter by 1 hour 51 minutes (p value 
0.001)  and the active phase by 35 minutes (p value 0.002). The total duration of 
labour was thus reduced by 2 hours 39 minutes in the Misoprostol only group. 
Although labour was shorter in BMI of <25 and >30 kg/m2 for the Misoprostol only 
arm, this was not statistically significant. 
The incidence of chorioamnionitis was nearly equal in both arms contrary to the 
findings in Chen et al meta analysis where combination arm had higher incidence of 
chorioamnionitis.  
Post partum haemorrhage was slightly higher in the Misoprostol only group, but this 
was not statistically significant. 
Endomyometritis seemed to be more frequent in the Misoprostol Only arm, and 
wound infections more common in the Misoprostol and Foleys arms. Neither of these 
findings reached statistical significance. 
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More babies in the Misoprostol group (27 babies, 17.9%) were diagnosed with 
neonatal sepsis compared to the Misoprostol and Foleys arm (20 babies, 13.4%), 
however this was not statistically significant.  
When using Misoprostol alone, there is a higher risk for meconium staining of liquor, 
hyperstimulation and ultimately Caesarean section/ Instrumental deliveries. 
In conclusion, according to our findings inducing labour in low risk primigravidas 
with Misoprostol alone is beneficial as it has shorter induction to delivery intervals 
and shorter overall time in labour (by 2 hours) as compared to patients induced with 
Misoprostol and Foleys. In women who are overweight (BMI 25 to 29.9 kg/m2, 
labour is 2 hours 39 minutes shorter. 
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CONCLUSIONS 
 
 Misoprostol alone seems to have the following advantages as compared to 
misoprostol with Foleys together :  
1. Shorter induction to delivery interval  
2. Shorter overall duration of labour  
3. Useful in unfavourable cervix ( bishop score < 4)  
4. After subgroup analysis, in overweight women (BMI 25 to 29.9 kg/m2), it 
shortened duration of labour( statistically significant) 
 Even though these findings are statistically significant in our study, our 
numbers are underpowered to advocate Misoprostol as the best agent for 
induction of labour.   
 
 Use of Misoprostol alone results in higher rates of Meconium stained liquor, 
hyperstimulation requiring Terbutaline and subsequently a higher Caesarean 
rates/ Instrumental deliveries in these patients. 
 
 There is no statistical difference in infectious and neonatal morbidity in the two 
groups. 
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LIMITATIONS 
 The main limitation of this study was that we were unable to achieve target 
sample size of 620 in the time period of one year. We will be continuing this 
study, and hope to achieve target sample size. 
 
 Due to the inherent study design, we were unable to blind caregivers and 
patients to the arm in which the patient was randomised. 
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ANNEXURE 
     Proforma Misofol 
     
      
1. Name  
  
2. Allocation 
Number 
  
      3. Hospital Number 
     
      4. Age (in years) 
     
      5.randomisation arm 
     
      6. place 
     
      7. Gestational age in weeks 
     
      8.BMI(kg/m2) 
     
      9. bishop score 
     
      10. induction to active labor(hrs) 
     
      11. active labor to delivery(hrs) 
     
      12. induction to delivery(hrs) 
     
      13. epidural use 1. yes 2. no 
   
      14. hyperstimulation/terbutaline use 1. yes 2. no 
   
      15. mode of delivery 1. normal 2. instrumental 3. lscs 
  
      16. indication for lscs 
     
      17. sex of baby 1. boy 2. girl 
   
      18. weight of baby(kg) 
     
      19.maternal complications 1. chorioamnionitis 2. pph 
   
      
20. If maternal fever, focus of infection 1. Endometritis 2.  UTI 3. Sepsis 
4. Thromboembolic 
complications 5.Pneumonia 
      21. Admission to ICU for mother 1. Yes 2. No 
   
      22. Neonatal sepsis 1. Culture Proven 2. Probable sepsis 3. No sepsis 
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      Informed Consent form to participate in a research study 
 
Study Title: Misofol 
 
Study Number: 
 
Subject‟s Initials: _________ Subject‟s Name: ________ 
 
Date of Birth / Age:_______ 
Please initial box  
(Subject) 
 
(i) I confirm that I have read and understood the information sheet dated _________ 
for the above study and have had the opportunity to ask questions. [    ] 
 
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or 
legal rights being affected. [    ] 
 
(iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor‟s 
behalf, the Ethics Committee and the regulatory authorities will not need my 
permission to look at my health records both in respect of the current study and any 
further research that may be conducted in relation to it, even if I withdraw from the 
trial. I agree to this access. However, I understand that my identity will not be 
revealed in any information released to third parties or published. [    ] 
 
(iv) I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s) [    ] 
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(v) I agree to take part in the above study. [    ] 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory‟s Name: _________________________________ 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator‟s Name: _________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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Patient Information Sheet 
 
Your Doctor has decided that it is time to deliver your baby.  
For the process of labour to begin, the cervical part (mouth) of the uterus needs to be 
softened. This can be done in two ways- by inserting a tube filled with fluid to distend 
the mouth of the uterus (Foleys catheter), by a tablet (Misoprostol) or by a 
combination of these two methods.  
We are conducting a study which seeks to compare the efficacy of Foleys combined 
with Misoprostol versus Misoprostol alone.  
You are being invited to participate in this study. 
You will have no benefits or major complications by being part of this study. 
However, for some reason if you do not choose to be part of this study you will have 
no disadvantage. Very few patients may have infection of the uterus which is 
treatable with antibiotics. You always have the option of withdrawing from the 
study without your medical care being affected. 
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SPSS data entry variables 
 
Name  Hospi no ser no Rand no age place BMI BS risk GA
 latent ph total durat act ph MSAf Epid use hyperst mode deli ind of lscs chorio
 fever nicu admission apgar  
pavani           019225g  1 1 2 1 2 1 5 2
 12.00 21.32 9.32 2 2 2 2 1 3.32 4 2 3
 4 2 3 1 1 3 
sumathi          044055c  2 2 2 2 5 1 4 2
 11.40 18.49 7.09 2 2 2 2 1 3.52 4 2 3
 4 2 3 1 1 3 
sudha            047382g  3 1 2 3 4 2 5 2
 10.15 16.27 6.12 2 2 2 1 2 3.13 4 2 3
 4 2 3 1 1 3 
vidhya           241960g  4 1 2 1 2 1 1 2
 12.00 26.00 5.00 2 2 2 3 2 3.90 3 2 3
 4 2 3 1 1 3 
monika           188520g  5 2 2 1 4 2 1 2
 13.35 17.40 5.05 1 2 2 1 2 3.19 4 2 3
 4 2 3 1 1 1 
ezhil            122829f  6 2 2 3 4 1 1 2
 12.00 24.00 0.00 2 2 2 3 2 3.02 3 2 3
 4 2 3 1 1 3 
pramila          297912g  7 1 2 1 2 2 1 2
 7.30 11.45 4.15 1 2 1 1 2 3.04 4 2 3
 4 2 3 1 1 2 
yamuna           220399g  8 2 2 1 4 1 1 2
 16.15 28.10 12.05 2 1 1 3 1 2.72 1 1 1
 4 2 2 1 1 3 
sudha            931818f  9 1 3 3 4 1 3 2
 10.30 26.30 16.00 2 2 2 3 1 3.48 3 2 3
 4 2 2 1 1 3 
81 
 
vaitheswar       340936g  10 2 2 1 5 1 2 2
 12.00 30.00 0.00 1 1 2 3 2 3.46 3 2 1
 5 2 3 1 1 1 
rani             143610g  11 1 2 1 2 1 1 2
 12.00 18.30 6.30 2 2 2 1 2 3.28 4 2 3
 4 2 3 1 1 3 
getchyl          146469g  12 2 2 1 2 1 1 2
 10.00 26.00 16.00 2 1 2 3 2 3.50 3 2 3
 4 2 3 1 1 3 
hemalatha        147753g  13 1 2 1 2 2 1 2
 11.00 20.10 9.10 1 2 2 3 2 3.52 1 2 3
 4 2 3 1 1 1 
archana          193996g  14 1 2 1 2 2 1 2
 9.30 16.00 6.30 1 2 2 1 1 2.80 4 2 3
 4 2 3 1 1 1 
aruna            760091f  15 2 3 1 5 1 4 2
 13.30 18.00 4.30 1 1 2 2 2 2.70 4 2 3
 4 2 3 1 1 1 
jeeva            186874g  16 1 2 1 4 1 2 2
 16.00 22.30 6.30 2 1 2 2 1 3.24 4 2 3
 5 2 2 1 1 3 
hema             153424g  17 2 2 3 4 1 1 2
 10.00 20.42 10.42 2 2 2 3 1 2.92 1 2 3
 4 2 3 1 1 3 
kalaivani        155490g  18 1 2 1 2 2 1 2
 11.00 21.00 12.00 2 2 2 3 1 3.18 2 2 3
 4 2 3 1 1 3 
esther           155584g  19 2 2 1 2 1 1 2
 12.00 20.00 8.00 2 2 2 3 2 3.40 2 2 3
 4 2 3 1 1 3 
deepika          364346g  20 1 2 3 4 1 5 2
 13.30 16.00 2.30 1 1 1 3 2 2.92 1 1 1
 3 1 2 1 1 2 
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naveena          208606g  21 2 2 3 2 2 1 2
 16.00 21.15 5.15 1 2 1 2 2 2.93 4 2 3
 4 2 3 1 1 1 
madhapalli       198218g  22 1 3 3 4 2 3 2
 10.00 17.35 7.35 2 1 2 2 2 2.92 4 2 3
 4 2 3 1 1 3 
miruna           260983g  23 2 2 3 2 2 1 2
 13.15 17.45 4.30 2 2 2 2 2 3.06 4 2 3
 4 2 3 1 1 3 
arti             259170g  24 1 1 1 2 2 5 2
 6.00 9.15 3.15 1 2 1 2 2 2.80 4 2 3
 4 1 1 2 1 1 
devi             395765g  25 1 2 1 4 1 2 2
 6.00 10.30 4.30 2 2 2 3 2 3.80 2 2 3
 4 2 3 1 1 3 
priyanka         279090g  26 2 2 2 4 1 2 2
 6.00 10.15 4.15 1 2 1 3 2 2.60 1 2 3
 5 1 2 1 1 1 
krishna          769424f  27 2 2 2 2 1 1 2
 12.00 30.00 0.00 2 1 2 3 1 3.58 3 2 3
 4 2 3 1 1 3 
shanbag          163936g  28 1 2 1 2 1 5 2
 10.00 21.56 11.56 2 1 2 1 1 3.18 4 2 3
 4 2 3 1 1 3 
vidhya           147472c  29 2 3 3 2 2 3 2
 12.00 16.20 6.20 2 2 2 2 1 3.98 4 2 3
 4 2 3 1 1 3 
parameswar       352340g  30 1 2 1 2 2 1 2
 13.00 18.15 5.15 2 2 2 1 2 3.40 4 2 3
 4 2 3 1 1 3 
sandhiya         182304g  31 2 2 1 2 1 1 2
 9.00 17.00 8.00 2 2 2 2 1 3.33 4 2 3
 4 2 3 1 1 3 
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vanitha k        914475f  32 1 2 1 4 2 1 2
 5.00 8.15 3.15 2 2 2 1 2 3.33 4 2 3
 4 2 3 1 1 3 
vandana m        417896g  33 2 1 3 2 2 1 1
 7.00 13.00 6.00 2 2 2 1 2 2.43 4 2 3
 4 2 3 1 1 3 
asina            397535g  34 1 2 1 5 1 4 2
 12.30 25.30 0.00 2 2 1 3 2 3.10 3 2 3
 4 2 2 1 1 3 
kavita d         274717g  35 2 2 1 5 2 4 2
 10.00 14.05 4.05 2 2 2 1 2 2.85 4 2 3
 4 2 3 1 1 3 
renuka devi      165328g  36 1 2 1 2 2 1 2
 6.00 14.10 8.10 1 2 2 1 2 2.50 4 2 3
 4 2 2 1 1 1 
saranya v        702160f  37 1 2 1 2 2 1 2
 7.00 13.00 6.00 2 2 2 1 2 2.83 4 2 3
 4 2 3 1 1 3 
ezhilarasi       172083g  38 2 2 2 4 1 1 2
 12.00 18.30 8.30 2 2 2 2 2 3.29 4 2 3
 5 2 2 1 1 3 
keertiga         417811g  39 2 2 1 2 1 1 2
 9.30 16.30 7.00 2 1 2 1 1 2.97 4 2 1
 4 2 3 1 1 3 
anandhi sp       264515g  40 1 2 2 5 1 4 2
 12.00 24.00 0.00 2 2 2 3 2 3.24 3 2 3
 4 2 3 1 1 3 
anusha           065092g  41 1 2 3 4 2 1 2
 8.00 13.30 5.30 1 2 2 2 2 3.74 4 2 3
 4 2 3 1 1 1 
megala           993562f  42 2 2 3 2 2 1 2
 6.45 16.15 7.30 1 2 1 2 2 3.17 4 1 1
 3 2 2 1 1 1 
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sumati           107569g  43 2 2 3 4 1 1 2
 8.00 13.00 5.00 2 2 2 2 1 2.50 4 2 3
 4 2 3 1 1 3 
vema joshna      379538g  44 1 2 3 4 2 1 2
 11.00 25.00 14.00 2 2 2 3 1 3.54 2 2 3
 4 2 2 1 1 3 
mahmoola         198506g  45 2 1 1 2 1 1 2
 12.15 22.15 10.00 1 2 2 2 1 3.19 4 2 3
 4 1 1 2 1 1 
selvi k          379005g  46 1 2 2 2 2 1 2
 10.00 14.00 4.00 2 2 2 3 2 2.40 1 2 3
 4 1 2 2 1 3 
sunita           229164g  47 1 2 1 4 2 5 2
 12.00 24.00 0.00 2 2 2 3 2 3.36 3 2 3
 4 2 2 1 1 3 
swapna           329646g  48 2 2 3 2 2 5 2
 5.30 10.00 4.30 2 2 2 2 2 2.61 4 2 3
 4 2 3 1 1 3 
fathima          297572g  49 2 2 1 2 1 1 2
 12.00 18.25 6.25 2 1 2 1 2 2.91 4 2 3
 4 2 3 1 1 3 
saritha          400833g  50 1 2 1 4 1 1 2
 8.00 20.30 0.00 2 2 1 3 1 3.38 3 2 3
 4 2 3 1 1 3 
senthamil        253488d  51 2 3 1 4 1 3 2
 10.00 28.00 0.00 2 1 2 3 1 3.32 3 2 3
 1 1 2 1 1 3 
vidivelli        165595g  52 1 2 1 2 2 1 2
 8.00 15.30 7.30 1 2 2 2 1 3.38 4 2 1
 4 2 3 1 1 1 
nirmala d        132469b  53 2 2 1 2 1 1 2
 12.00 18.40 6.40 2 2 2 2 2 2.95 4 2 3
 4 2 3 1 1 3 
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punita g         235140g  54 1 2 1 4 1 1 2
 13.00 16.00 3.00 1 2 2 3 1 3.98 1 2 3
 3 1 1 2 1 2 
uma r            174736g  55 1 2 1 2 1 2 2
 13.00 19.35 6.35 2 2 2 2 1 3.18 4 1 3
 3 2 2 1 1 3 
lavanya m        165745g  56 2 2 1 2 2 1 1
 11.14 17.38 6.24 2 2 1 2 1 3.00 4 2 3
 4 2 3 1 1 3 
sandhiya d       207940g  57 2 2 1 2 1 5 2
 8.35 18.50 10.15 2 1 1 3 2 2.92 1 2 3
 4 2 3 1 1 3 
thejasvi         027655b  58 1 2 3 4 2 1 2
 5.48 13.58 8.10 1 2 1 3 1 2.58 1 2 3
 4 2 3 1 1 1 
saranya s        179885g  59 2 1 1 1 1 1 2
 11.18 18.23 7.05 2 2 2 1 1 2.20 4 2 3
 4 2 2 1 1 3 
manjula          187876g  60 1 2 1 5 1 2 2
 12.30 24.30 12.00 2 2 1 3 1 3.56 2 2 1
 4 2 3 1 1 3 
madhuri          102079g  61 2 2 3 4 1 1 2
 12.00 24.00 0.00 2 2 2 3 2 3.10 3 2 3
 1 2 2 1 1 3 
silpa            171691g  62 2 2 3 2 1 1 2
 12.00 22.31 10.31 2 2 2 2 1 3.19 4 2 3
 4 2 3 1 1 3 
barani k         272375d  63 2 2 1 2 1 1 2
 8.50 18.10 9.30 2 2 2 1 1 3.32 4 2 3
 4 2 3 1 1 3 
aiswarya         180072g  64 1 2 1 4 1 1 2
 12.00 19.30 7.30 2 2 2 1 1 3.00 4 2 3
 4 2 3 1 1 3 
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israth           109049g  65 2 2 2 2 1 1 2
 8.00 16.00 8.00 1 2 2 2 1 3.07 4 2 3
 4 2 3 1 1 2 
sangeeta p       270871g  66 1 1 1 4 2 1 2
 6.00 10.30 4.30 1 2 2 1 1 2.87 4 2 3
 4 2 3 1 1 1 
sandhya          420343g  67 1 2 1 2 1 1 2
 12.00 20.00 8.00 2 2 1 3 2 2.80 1 1 1
 3 1 1 1 1 3 
sathyapriya      004225g  68 2 2 1 4 2 1 2
 10.35 17.45 7.10 2 2 2 1 1 3.60 4 2 3
 4 2 3 1 1 3 
sangeeta         012033d  69 1 3 2 5 1 3 2
 12.00 20.00 8.00 2 2 2 3 1 2.78 2 2 3
 4 2 3 1 1 3 
nithya           013496f  70 2 2 1 2 1 1 2
 10.00 18.00 6.00 2 2 2 3 1 3.56 2 2 3
 4 2 3 1 1 3 
sangeeta d       028439g  71 2 2 1 2 1 1 2
 13.45 19.10 6.40 2 2 2 1 2 2.52 4 2 3
 4 2 3 1 1 3 
ranatha          039222g  72 1 2 1 4 1 2 2
 6.40 16.50 10.10 2 2 1 3 2 3.28 2 2 2
 3 2 2 1 1 3 
roseline         062137f  73 1 2 1 2 1 5 2
 11.35 17.18 5.43 2 1 2 1 1 3.80 4 2 3
 4 2 3 1 1 3 
kavitha          227394g  74 2 2 1 4 1 1 2
 12.00 26.00 14.00 2 2 2 3 1 3.92 2 2 3
 4 2 3 1 1 3 
kavita k         097120g  75 1 2 3 4 1 2 2
 8.45 20.10 11.35 2 2 1 3 1 2.32 3 2 3
 4 2 3 1 1 3 
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gomathy          099095f  76 2 2 1 2 1 1 2
 9.45 18.13 8.30 2 2 2 3 2 3.80 1 2 3
 4 2 3 1 1 3 
saranya m        104179g  77 1 2 1 2 2 1 2
 5.44 11.55 6.30 1 2 2 2 1 3.69 4 2 1
 4 2 3 1 1 2 
sasikala         107663f  78 2 2 3 4 2 1 2
 7.30 13.15 6.10 2 2 2 3 1 2.68 1 2 3
 4 2 3 1 1 3 
rajalakshmi      115308f  79 2 2 1 2 1 1 2
 8.00 14.55 6.55 2 1 2 1 2 2.93 4 2 3
 4 2 3 1 1 3 
priyadarshini    120297g  80 1 2 1 2 1 1 2
 9.30 17.15 7.45 2 2 2 1 2 3.70 4 2 3
 4 2 3 1 1 3 
sharmila         130565f  81 1 2 1 4 2 5 2
 8.43 13.55 5.05 1 2 1 3 2 3.54 1 2 3
 4 2 3 1 1 1 
nageswarama      198217g  82 2 2 3 2 1 1 2
 10.05 16.45 6.40 2 2 2 1 2 2.92 4 2 3
 4 2 3 1 1 3 
vandana          194687g  83 1 2 1 2 1 5 2
 8.00 17.45 0.00 2 1 2 3 2 3.60 3 2 3
 4 2 3 1 1 3 
narmadha m       131808b  84 2 2 1 2 2 1 1
 7.25 15.40 8.15 2 2 2 1 2 2.30 4 2 3
 4 1 2 1 1 3 
saranya          212348g  85 2 2 1 4 1 1 2
 12.30 23.00 10.30 2 2 2 3 1 3.00 2 2 3
 5 2 3 1 1 3 
asha s           190874g  86 1 1 3 2 1 1 2
 10.00 17.40 7.40 2 2 2 1 2 3.40 4 2 3
 4 2 3 1 1 3 
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yagalaksmi       213532g  87 1 2 2 5 2 4 2
 6.00 12.45 0.00 1 2 1 3 2 2.76 1 2 3
 3 2 2 1 1 2 
malathy          188718g  88 2 2 1 2 1 1 2
 10.10 15.50 5.40 2 2 2 2 1 3.07 4 2 3
 4 2 3 1 1 3 
tasneem          199339g  89 1 2 1 2 2 1 2
 10.15 16.40 0.00 2 2 2 3 2 3.28 3 2 3
 4 2 3 1 1 3 
koteswari        198812g  90 2 2 1 2 1 1 2
 12.30 20.15 7.45 2 2 2 2 2 2.95 4 2 3
 4 2 3 1 1 3 
venu g           190476g  91 1 2 3 4 2 2 2
 11.10 17.27 6.17 1 1 2 1 2 2.95 4 2 3
 4 2 3 1 1 1 
hajira           285759g  92 2 2 2 2 1 1 2
 11.45 15.43 4.58 2 2 2 1 2 2.83 4 2 3
 4 2 3 1 1 3 
aysa             375741g  93 1 1 1 2 2 5 2
 7.50 11.27 3.37 2 2 2 1 2 3.36 4 2 3
 4 1 2 1 1 3 
saranya s        390454g  94 2 3 2 4 1 3 2
 12.00 26.00 14.00 2 2 2 3 1 3.48 2 2 1
 4 2 2 1 1 3 
lakshmipriya     300397f  95 2 2 2 2 1 5 2
 12.00 17.35 0.00 2 2 2 3 2 3.62 1 2 3
 4 2 3 1 1 3 
suganya          206537g  96 1 2 1 5 2 3 2
 11.31 15.45 4.14 1 2 2 3 1 3.60 1 2 3
 4 2 2 1 1 1 
varalaxmi        204726g  97 1 2 2 4 1 5 2
 10.40 19.10 9.50 1 1 2 2 2 3.10 1 1 3
 4 2 2 1 1 1 
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sangeeta k       203450g  98 2 2 1 2 2 1 2
 8.50 13.45 4.50 2 2 2 1 1 2.84 4 2 3
 4 2 3 1 1 3 
lavanya m        203006g  99 1 2 1 4 2 1 2
 5.50 14.02 8.12 1 1 2 1 1 3.69 4 2 3
 4 2 3 1 1 1 
uma maheswari    295704g  100 2 2 3 4 2 1 2
 11.00 21.00 10.00 2 2 2 2 1 2.90 4 2 3
 4 2 3 1 1 3 
keertana j       249438g  101 2 1 1 2 1 5 2
 12.00 18.30 6.30 2 2 2 1 2 3.46 4 2 3
 4 2 3 1 1 3 
sangeeta         270881g  102 1 1 1 5 2 4 2
 7.45 13.03 5.58 2 2 2 1 1 2.87 4 2 3
 4 2 3 1 1 3 
monika k         387436g  103 2 1 3 4 1 5 2
 9.30 14.35 5.05 2 2 2 1 1 3.36 4 2 3
 4 2 3 1 1 3 
silambarasi      283063g  104 1 2 1 4 2 1 2
 6.30 12.45 6.15 1 2 2 2 1 2.80 4 2 3
 4 2 3 1 1 1 
shanmugpriya     199428g  105 1 2 2 1 2 5 2
 5.45 11.51 6.05 2 2 2 1 1 2.79 4 2 3
 4 2 3 1 1 3 
sangeeta k       203457g  106 2 3 1 4 1 1 2
 12.07 19.37 7.30 2 2 1 1 1 2.84 4 2 3
 4 2 3 1 1 3 
venda            225126g  107 1 2 1 2 1 1 2
 13.10 24.55 11.45 2 1 2 2 2 3.40 4 2 1
 4 2 3 1 1 3 
rekha r          326205g  108 2 2 1 2 1 1 2
 12.15 16.35 4.20 2 2 2 1 1 3.23 4 2 3
 4 2 3 1 1 3 
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abirami          178102g  109 2 2 2 2 1 2 1
 12.00 24.00 12.00 2 2 2 2 1 2.50 4 2 3
 4 2 3 1 1 3 
radhika a        067497g  110 1 3 1 4 1 2 2
 9.30 17.15 7.45 2 2 2 2 1 2.84 4 2 3
 4 2 3 1 1 3 
imrana a         208345g  111 2 2 2 2 2 1 2
 8.40 12.50 4.10 2 2 2 2 1 3.59 4 2 3
 4 2 3 1 1 3 
parimala devi    208133g  112 1 3 1 4 1 7 2
 11.15 17.15 6.00 1 2 2 2 1 3.34 4 2 3
 4 2 3 1 1 2 
jayanthi v       178212g  113 1 2 2 4 2 2 2
 7.50 13.30 6.40 2 2 1 1 1 2.79 4 2 3
 4 2 3 1 1 3 
parveen m        241155g  114 2 2 2 2 1 1 2
 12.00 19.10 7.10 2 2 2 1 2 3.10 4 2 3
 4 1 3 1 1 3 
brinda           407968f  115 2 2 1 2 1 1 2
 10.40 22.00 12.00 2 2 2 2 2 3.24 4 2 3
 4 2 3 1 1 3 
pramila c        260565g  116 1 2 3 5 2 3 2
 11.30 19.30 8.00 1 1 2 2 1 3.34 4 2 1
 4 2 3 1 1 1 
saira            312078g  117 2 2 3 2 1 2 2
 12.00 19.00 7.00 2 2 2 2 2 3.70 4 2 2
 4 2 3 1 1 3 
saranya s        208659g  118 1 2 2 4 2 1 2
 8.30 13.45 5.15 2 2 2 2 1 2.94 4 2 3
 4 2 3 1 1 3 
santhiya         208831g  119 1 2 1 2 1 1 2
 10.15 17.30 7.15 1 2 2 1 2 2.63 4 2 3
 4 1 2 1 1 1 
91 
 
suganya          211222g  120 2 2 3 4 1 2 2
 12.00 16.00 0.00 2 2 2 3 1 2.00 3 1 1
 3 1 2 1 1 3 
sandhiya s       212200g  121 1 2 1 2 2 1 2
 7.50 15.51 8.00 2 1 2 1 2 2.81 4 2 3
 4 2 3 1 1 3 
malathi          211006g  122 2 2 2 5 1 4 2
 10.35 13.00 0.00 1 2 1 3 1 2.00 3 2 3
 4 2 3 1 1 1 
dhanalakshmi d   210655g  123 1 2 1 2 2 1 2
 10.30 20.00 9.30 2 2 2 2 1 3.08 4 2 3
 4 1 2 1 1 3 
sathya m         210590g  124 2 1 1 2 1 1 2
 10.00 17.14 7.14 2 2 2 2 2 3.00 4 2 3
 4 2 3 1 1 3 
gowthami         210331g  125 1 2 1 4 1 1 2
 8.00 18.00 0.00 2 2 2 3 2 3.42 3 2 3
 4 2 3 1 1 3 
vinitha          213511g  126 2 1 2 2 1 1 2
 10.32 16.45 6.15 2 2 2 1 2 2.84 4 2 3
 4 2 3 1 1 3 
rekha r          212419g  127 2 1 1 5 1 3 2
 12.00 19.13 7.13 2 2 2 2 1 3.05 4 2 1
 4 2 3 1 1 3 
sonia            213072g  128 1 1 1 4 2 1 2
 8.00 14.12 6.12 2 2 2 1 2 2.83 4 2 3
 4 2 3 1 1 3 
saranya          212248g  129 2 2 1 4 1 1 2
 12.00 28.00 16.00 2 2 1 3 1 3.00 1 2 3
 5 2 3 1 1 3 
rajeswari a      213538g  130 1 2 2 2 2 1 2
 10.00 17.17 7.17 1 2 2 1 2 3.07 4 2 3
 4 2 3 1 1 1 
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vidhyalakshmi    014334f  131 1 2 2 4 1 2 1
 10.00 16.43 6.43 2 2 2 1 2 2.80 4 2 3
 4 2 3 1 1 3 
kavyasree        014403g  132 2 2 3 2 1 1 2
 12.20 18.48 6.28 2 1 2 1 1 3.00 4 2 3
 4 2 3 1 1 3 
swetha v         061105d  133 1 2 2 4 1 1 2
 11.00 16.34 5.34 2 2 2 2 1 3.58 3 2 3
 5 2 3 1 1 3 
reshma           085445g  134 2 2 1 2 2 1 2
 12.00 16.11 4.11 2 2 2 2 2 3.02 4 2 3
 4 2 3 1 1 3 
jeyapriya s      089037d  135 1 2 1 4 2 1 2
 10.00 17.00 7.00 2 2 2 1 1 3.36 4 2 3
 4 2 3 1 1 3 
sasikala         121986g  136 2 3 1 5 1 3 1
 8.00 22.00 14.00 2 2 2 3 2 3.30 2 2 3
 4 2 3 1 1 3 
sasikala         123236g  137 1 2 2 2 1 2 2
 10.30 16.53 6.23 1 2 2 1 2 3.03 4 2 1
 4 2 3 1 1 1 
nikila           126520g  138 2 2 3 2 1 1 2
 11.30 18.22 6.44 2 2 2 2 2 3.11 4 2 3
 4 2 3 1 1 3 
bayis            140050g  139 2 1 1 5 1 3 2
 8.00 4.35 0.00 2 2 2 3 2 3.03 1 1 3
 4 1 2 1 1 3 
shenaz           151918g  140 1 2 2 2 1 1 2
 9.30 14.48 5.18 2 2 2 1 2 3.10 4 2 3
 4 2 3 1 1 3 
swmya            152800g  141 2 2 2 4 1 1 2
 12.00 20.13 8.00 2 2 2 1 1 3.30 4 2 3
 4 2 3 1 1 3 
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nithya           163677g  142 1 2 2 2 1 2 2
 11.30 17.47 7.17 2 2 2 2 1 3.22 4 2 3
 4 2 3 1 1 3 
ramalaksh        239767g  143 2 2 1 4 1 1 2
 12.00 17.56 5.56 2 2 2 2 1 3.00 4 2 3
 4 2 3 1 1 3 
sathya g         167277g  144 1 2 2 2 1 1 2
 9.30 15.45 6.15 1 2 1 2 1 3.12 4 2 1
 4 2 3 1 1 2 
uma              172334g  145 1 2 1 4 2 2 1
 11.00 17.30 6.30 2 2 2 2 1 2.68 4 2 2
 4 2 3 1 1 3 
induja           174624g  146 2 2 1 5 2 3 2
 11.03 18.43 7.40 1 2 2 2 2 3.56 4 2 3
 4 2 3 1 1 1 
priya            175017g  147 2 3 1 2 1 1 2
 12.00 28.00 16.00 2 2 2 3 1 1.00 3 1 3
 4 2 2 1 1 3 
iswar            175076g  148 1 2 1 5 2 3 2
 11.00 18.34 7.34 2 1 2 2 2 3.10 4 2 3
 4 2 3 1 1 3 
aishya i         176511f  149 2 2 1 2 1 1 2
 10.40 16.50 6.10 2 2 2 1 1 3.12 4 2 3
 4 2 3 1 1 3 
shajida          184719g  150 1 2 1 4 1 1 2
 12.00 16.50 4.50 2 2 2 1 1 3.48 4 2 3
 4 2 3 1 1 3 
vaishna          185741g  151 1 2 1 2 2 1 2
 10.40 15.57 5.10 2 2 2 2 1 2.99 4 2 3
 4 2 3 1 1 3 
divya            176882g  152 2 2 1 4 1 1 2
 12.00 20.00 0.00 1 2 2 3 2 3.48 1 2 3
 6 2 3 1 1 1 
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rajeswari        182232g  153 2 2 1 2 1 1 2
 12.00 17.57 5.57 2 1 1 1 2 2.80 4 2 3
 4 2 3 1 1 3 
geeta            181859g  154 1 2 2 4 1 1 2
 10.15 17.45 7.30 2 2 2 1 2 2.80 4 2 3
 4 2 3 1 1 3 
ameena           180953g  155 1 2 1 2 1 1 2
 12.00 22.00 10.00 2 2 2 2 1 3.24 4 2 3
 4 2 3 1 1 3 
komathi          179680g  156 2 2 1 4 1 1 2
 12.00 21.51 9.51 2 2 1 1 1 3.64 4 2 3
 4 2 3 1 1 3 
jyoti            179282f  157 1 2 3 2 1 1 2
 11.00 19.23 8.23 2 2 2 2 1 2.83 4 2 1
 4 2 2 1 1 3 
pavitra          178642g  158 2 2 3 5 2 3 1
 8.40 14.50 6.10 2 2 2 1 1 2.93 4 2 3
 4 2 3 1 1 3 
geeta            201044g  159 2 2 1 4 1 1 2
 9.50 23.15 0.00 2 1 2 3 1 2.68 3 1 3
 4 1 2 1 1 3 
jyoti            192719g  160 1 2 1 2 1 5 2
 12.00 20.00 0.00 1 2 1 3 1 2.54 1 2 3
 3 2 1 1 1 1 
banupriya        194871g  161 2 2 1 4 1 2 2
 10.00 15.41 5.00 2 2 2 3 2 2.86 1 2 3
 4 2 3 1 1 3 
saranya          195973g  162 1 2 1 2 1 5 2
 12.00 24.00 0.00 2 2 2 3 2 2.68 3 2 3
 4 2 3 1 1 3 
mythili          197101g  163 1 2 3 2 1 2 2
 9.00 16.33 7.33 2 2 2 1 2 2.45 4 2 3
 4 2 3 1 1 3 
95 
 
kaplana          197112g  164 2 2 3 4 1 2 2
 12.00 18.27 6.27 2 2 2 2 1 3.40 4 2 1
 4 2 3 1 1 3 
jayachitra       197278g  165 2 2 2 2 1 1 2
 10.30 20.47 10.17 2 2 2 2 2 2.70 4 2 3
 4 2 3 1 1 3 
devi             197417g  166 1 1 1 5 1 1 2
 13.00 21.24 8.24 2 1 2 1 2 3.26 4 2 3
 4 2 3 1 1 3 
raheela          198045g  167 2 2 1 2 2 5 2
 12.00 21.43 9.43 2 2 2 3 2 3.12 1 2 3
 4 2 3 1 1 3 
triveni          199763g  168 1 2 3 2 1 2 2
 12.00 23.56 11.56 2 2 2 1 1 2.90 4 2 3
 4 2 3 1 1 3 
kavita           202985g  169 1 2 1 4 1 1 2
 13.00 22.11 9.11 1 2 2 1 1 3.37 4 2 3
 4 2 3 1 1 1 
usha             200024g  170 2 3 1 4 1 2 2
 11.30 20.55 9.25 2 2 2 2 1 3.26 4 2 3
 4 2 3 1 1 3 
anitha           404573g  171 2 2 3 2 1 1 2
 12.00 22.46 10.46 2 1 2 1 2 2.88 4 2 3
 4 2 3 1 1 3 
nisa rh          417178g  172 1 2 2 2 1 1 2
 10.00 17.10 7.10 2 2 2 1 1 3.45 4 2 1
 4 2 3 1 1 3 
deepa l          325700g  173 2 2 2 4 2 2 2
 9.45 17.03 6.17 2 2 2 1 2 3.04 4 2 3
 4 2 3 1 1 3 
saranya          336331g  174 1 2 1 2 1 1 2
 12.00 23.55 11.55 2 2 2 1 2 3.05 4 2 3
 4 2 3 1 1 3 
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janani m         380600g  175 2 2 2 5 1 3 2
 13.00 25.17 12.17 2 2 2 3 2 2.86 1 2 3
 4 2 3 1 1 3 
tejovathy        412418g  176 1 2 3 2 2 1 2
 12.00 22.58 10.58 2 2 2 1 2 2.78 4 2 3
 4 2 3 1 1 3 
nandini g        375513g  177 1 2 2 1 2 5 2
 10.30 18.32 8.02 2 2 2 1 2 2.86 4 2 3
 4 2 3 1 1 3 
madhavi g        407095g  178 2 2 3 4 1 2 2
 12.00 18.34 0.00 2 2 2 3 1 3.36 1 1 3
 3 2 2 1 1 3 
suganya          381020g  179 1 2 1 4 1 2 2
 10.45 20.21 10.21 1 2 2 1 2 2.93 4 2 3
 4 2 3 1 1 1 
rajati           331089g  180 2 2 2 4 2 2 2
 12.00 23.40 11.40 2 2 2 1 1 3.01 4 2 3
 4 2 3 1 1 3 
devi r           291681g  181 1 2 1 2 2 1 2
 12.00 22.34 10.34 2 2 2 1 2 2.78 4 2 3
 5 2 3 1 1 3 
valarmathy       277025g  182 2 1 1 2 1 1 2
 12.00 21.03 9.03 2 2 2 1 2 3.44 4 2 3
 4 2 3 1 1 3 
kanimozhi        366955g  183 1 2 1 2 1 1 2
 10.00 19.50 9.50 2 2 2 1 1 3.20 4 2 3
 4 2 3 1 1 3 
sivasakti        299775g  184 2 2 1 4 1 1 2
 13.00 20.47 7.47 2 2 2 1 2 3.29 4 2 3
 5 2 3 1 1 3 
hina f           411664g  185 2 1 2 2 1 5 2
 12.00 18.49 8.49 2 2 1 3 1 3.26 1 2 3
 4 2 3 1 1 3 
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anitha k         325221g  186 1 2 1 2 2 1 2
 7.30 17.07 9.37 2 2 2 1 2 3.40 4 2 3
 4 2 3 1 1 3 
saraswati d      427970g  187 1 3 2 4 2 3 2
 10.00 16.04 6.04 2 2 2 1 1 3.17 4 2 3
 4 2 3 1 1 3 
sheela           355023g  188 2 2 3 2 1 5 2
 12.00 21.39 9.39 2 2 2 1 1 3.10 4 2 3
 4 2 3 1 1 3 
keerthiga        408354g  189 2 2 2 4 2 1 2
 13.00 21.23 8.23 2 2 2 2 2 2.75 4 2 3
 4 2 3 1 1 3 
devi s           308025g  190 1 2 1 5 2 4 2
 12.00 25.40 11.42 2 2 2 2 2 2.41 4 2 3
 4 1 2 1 1 3 
nouhira          288575g  191 1 2 3 2 1 1 2
 10.30 21.10 10.20 1 2 2 2 1 3.54 4 2 3
 4 2 3 1 1 2 
sujatha          996561f  192 2 2 1 2 2 1 2
 7.00 15.29 8.29 2 2 2 1 1 2.66 4 2 3
 4 2 3 1 1 3 
sinesa           369445g  193 2 2 3 4 1 1 2
 12.00 22.52 10.52 2 2 2 1 2 3.13 4 2 3
 4 2 3 1 1 3 
monisha r        321927g  194 1 1 2 2 2 1 2
 10.00 20.03 10.03 2 2 2 1 2 2.92 4 2 3
 4 2 3 1 1 3 
keerthana d      369998g  195 1 2 3 4 1 5 2
 8.00 23.43 15.43 2 1 2 3 2 3.82 2 2 3
 1 2 3 1 1 3 
jhanvi           295338g  196 2 2 3 2 1 1 2
 12.00 18.02 8.02 2 2 2 1 2 3.01 4 2 3
 4 2 3 1 1 3 
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thabassum        241598g  197 1 2 1 2 2 2 2
 10.00 21.42 11.42 2 2 2 1 2 3.10 4 2 3
 4 2 3 1 1 3 
anjalai          402207g  198 2 3 3 4 1 3 2
 12.00 19.48 7.48 2 2 2 1 2 3.08 4 2 3
 4 2 3 1 1 3 
divya v          378643g  199 2 2 2 2 1 1 2
 12.00 26.39 14.39 2 2 2 2 2 3.62 4 2 1
 5 2 3 1 1 3 
dhivya           430172f  200 1 2 1 4 1 1 2
 10.00 20.39 10.39 1 2 1 1 2 3.48 4 2 3
 4 2 3 1 1 1 
sujatha          433386g  201 2 2 1 2 1 1 2
 11.00 25.00 6.00 2 2 2 3 1 3.26 3 2 3
 4 2 3 1 1 3 
hemavathi        390805g  202 1 1 3 2 1 1 2
 12.00 23.10 11.10 2 2 2 2 1 3.40 4 2 3
 4 2 3 1 1 3 
meghala          340253g  203 1 2 1 4 2 1 2
 10.00 22.00 0.00 1 2 2 3 2 3.10 3 2 3
 1 2 3 1 1 2 
shermila         332445g  204 2 2 1 2 1 1 2
 12.00 22.30 10.30 2 2 2 2 1 3.68 4 2 3
 4 2 3 1 1 3 
monika           396921g  205 2 2 1 2 1 1 2
 11.30 25.30 14.00 2 2 2 2 2 3.10 4 2 3
 4 2 3 1 1 3 
vinothini        467021f  206 1 2 1 4 1 1 2
 12.00 20.50 8.50 2 2 2 2 2 3.10 4 2 3
 4 2 3 1 1 3 
banu             356547g  207 1 2 1 4 1 1 2
 10.00 17.17 7.17 2 2 2 1 2 2.73 4 2 3
 4 2 3 1 1 3 
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divya            299631g  208 2 2 1 5 1 3 2
 10.00 19.43 9.43 2 2 2 1 2 2.78 4 2 3
 4 2 3 1 1 3 
rekha            338387g  209 1 2 2 2 1 2 2
 10.00 17.50 7.50 2 2 2 1 2 2.62 4 2 3
 4 2 3 1 1 3 
padmapriya       317305f  210 2 2 1 4 1 1 2
 12.00 25.00 13.00 2 2 2 1 1 3.30 4 2 3
 5 2 2 1 1 3 
chetana          511142f  211 2 2 2 2 1 1 2
 12.00 19.45 7.45 2 2 2 3 1 2.94 4 2 3
 4 2 3 1 1 3 
priyanka b       516340f  212 1 2 3 4 1 1 2
 11.00 19.00 8.00 2 2 2 1 2 2.79 4 2 3
 4 2 3 1 1 3 
yasmin           288215g  213 2 2 2 2 2 1 2
 12.00 25.33 13.33 2 2 2 2 1 3.03 4 2 3
 1 2 3 1 1 3 
punitavalli      339933g  214 1 2 2 4 1 1 2
 11.30 23.40 12.40 2 2 2 3 2 3.84 2 2 3
 4 2 3 1 1 3 
prema s          352169g  215 1 2 1 2 1 2 2
 12.00 20.20 8.20 2 2 2 2 2 3.00 4 2 3
 4 2 2 1 1 3 
salma            387310g  216 2 2 1 4 2 5 2
 10.00 16.50 6.50 2 2 2 2 1 3.40 4 2 3
 4 2 3 1 1 3 
shalini b        278536g  217 2 2 1 2 1 1 2
 12.00 26.00 0.00 2 2 2 3 1 3.70 4 2 3
 4 2 3 1 1 3 
bhuvaneswari     993572f  218 1 2 2 4 1 1 2
 12.00 19.20 7.20 2 2 2 1 1 3.52 4 2 3
 4 2 3 1 1 3 
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induja           863294c  219 2 2 1 2 1 1 2
 10.00 18.46 8.46 2 2 2 1 1 3.41 4 2 3
 4 2 3 1 1 3 
selvi k          379006g  220 1 2 1 2 1 1 2
 12.00 17.30 0.00 1 2 2 3 2 2.40 1 2 3
 4 2 3 1 1 2 
saritha          400843g  221 1 2 1 4 1 1 2
 12.00 24.00 0.00 2 2 2 3 2 3.38 3 2 3
 4 2 3 1 1 3 
jeyalaxmi        318580g  222 2 2 2 5 1 3 2
 12.00 17.59 5.59 2 2 2 2 2 2.85 4 2 3
 4 2 3 1 1 3 
prema            399092g  223 2 2 2 2 1 2 2
 12.00 18.58 6.58 2 2 2 1 1 2.57 4 2 3
 4 2 3 1 1 3 
sharmila r       412862g  224 1 2 2 2 1 1 2
 12.00 18.33 6.33 2 2 2 2 1 3.20 4 2 3
 4 2 3 1 1 3 
amudha           996575f  225 2 2 1 2 1 1 2
 9.40 18.02 8.22 2 2 2 2 1 2.95 4 2 3
 4 2 3 1 1 3 
bhagyavathy c    338583g  226 1 2 1 5 2 3 2
 12.00 18.00 0.00 1 2 1 3 1 2.72 1 2 3
 5 2 3 1 1 1 
bhagavati        295003g  227 2 3 1 2 1 1 2
 12.00 17.43 0.00 1 2 2 3 1 2.84 1 2 3
 4 2 3 1 1 1 
rajalaxmi        107519g  228 1 2 1 4 1 1 2
 10.00 15.14 5.14 2 2 2 3 2 2.70 1 2 3
 4 2 3 1 1 3 
vanitha          435580g  229 1 2 2 4 1 1 2
 12.00 19.20 7.20 1 2 1 3 2 2.66 1 2 3
 4 2 3 1 1 1 
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fatima           275191g  230 2 2 1 2 1 5 2
 12.00 20.54 8.54 2 2 2 1 1 3.26 4 2 3
 4 2 3 1 1 3 
gajalakshmi      404598g  231 2 2 1 2 1 1 2
 13.00 25.00 12.00 2 2 2 1 2 3.09 4 2 3
 4 2 3 1 1 3 
sumangali        430445g  232 1 2 2 2 2 1 2
 11.30 21.25 0.00 1 2 2 3 2 3.30 3 2 3
 4 2 3 1 1 1 
lavanya          274608g  233 1 2 2 5 1 3 2
 12.00 22.57 10.57 2 2 2 1 2 3.02 4 1 3
 1 2 1 1 1 3 
roja m           418934g  234 2 2 2 2 1 1 2
 10.30 19.26 8.56 2 2 2 1 2 2.57 4 2 3
 4 2 3 1 1 3 
radhika          996557f  235 2 2 2 4 2 1 2
 12.30 22.42 10.12 2 2 2 2 1 2.75 4 2 3
 4 2 3 1 1 3 
hemavathy        295047g  236 1 1 1 2 1 5 2
 10.00 19.32 9.32 2 1 2 1 2 3.04 4 2 3
 4 2 3 1 1 3 
kavitha          996588f  237 2 2 1 4 1 1 2
 8.00 13.48 0.00 1 2 2 3 1 2.72 1 1 3
 4 2 2 1 1 1 
vani a           364953g  238 1 2 1 5 1 3 2
 12.00 23.35 11.35 2 2 2 2 1 2.67 4 2 3
 4 2 3 1 1 3 
sujita           969823b  239 1 2 3 4 2 2 2
 11.00 21.45 10.45 2 2 2 1 2 3.07 4 2 3
 4 2 3 1 1 3 
kalpana r        428458g  240 2 2 2 4 1 1 2
 13.00 24.34 11.34 2 2 2 1 2 2.87 4 2 3
 4 2 3 1 1 3 
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pavitra          286006g  241 1 2 1 2 2 1 2
 12.00 20.53 8.53 1 2 1 1 2 2.94 4 2 3
 4 2 3 1 1 1 
saranya          302375g  242 2 2 2 4 1 1 2
 12.00 25.50 13.50 2 2 2 2 1 3.57 4 2 3
 4 2 3 1 1 3 
anjali           390897g  243 1 1 3 1 1 5 1
 8.45 19.55 11.10 2 2 2 1 1 2.71 4 2 3
 4 2 3 1 1 3 
chandralekha     350508g  244 2 2 3 2 1 5 2
 13.00 23.51 10.51 2 2 2 2 1 3.10 4 2 3
 4 2 3 1 1 3 
hajira           315233g  245 1 2 1 4 2 5 2
 10.00 21.20 11.20 1 2 2 1 2 3.30 4 1 3
 3 2 2 1 1 1 
renuka devi      815680f  246 2 2 1 2 1 5 2
 12.00 24.34 12.34 2 1 2 1 2 3.33 4 2 3
 1 1 1 1 1 3 
deepika          297160g  247 2 2 2 2 1 5 2
 10.00 23.30 13.30 1 2 1 2 2 3.34 4 2 3
 4 2 3 1 1 2 
pavitra          109035g  248 1 2 2 4 2 1 2
 11.00 23.00 0.00 2 2 2 3 2 3.56 3 1 1
 1 2 2 1 1 3 
suganya          109037g  249 2 2 2 2 1 1 2
 12.00 19.41 7.41 2 2 2 1 1 3.61 4 2 3
 4 2 3 1 1 3 
prabhavathy      377747g  250 1 2 1 2 1 7 2
 9.40 16.52 7.12 2 2 2 1 2 3.11 4 2 3
 4 2 3 1 1 3 
barkhat          109044g  251 2 2 1 2 1 1 2
 12.00 21.27 9.27 2 2 2 2 2 2.95 4 2 3
 4 2 3 1 1 3 
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megala           378267g  252 1 2 2 2 1 5 2
 12.00 18.12 6.12 2 2 2 1 1 3.23 4 2 3
 4 2 3 1 1 3 
satya            334569g  253 1 1 1 4 2 1 2
 8.40 16.57 8.17 1 2 1 2 1 2.71 4 2 3
 1 1 1 2 1 1 
sudiya           333479g  254 2 2 1 5 1 3 2
 12.00 18.32 6.32 2 2 2 1 2 3.13 4 2 3
 1 2 2 1 1 3 
priyanka         392133g  255 1 2 1 4 1 1 2
 11.45 18.56 7.11 1 2 2 1 1 3.10 4 2 3
 4 2 3 1 1 1 
priya            467803g  256 2 2 2 2 1 5 2
 12.00 21.40 9.40 2 1 2 2 1 3.35 4 2 1
 4 2 3 1 1 3 
vaishnavi        417410g  257 1 2 2 2 2 5 2
 12.00 18.24 6.24 2 2 2 1 1 3.43 4 2 3
 4 2 3 1 1 3 
shamala          437343g  258 2 2 3 2 1 1 2
 10.00 15.50 5.51 2 2 2 2 2 3.00 4 2 2
 4 2 3 1 1 3 
priya s          320365g  259 2 2 1 4 1 1 2
 12.00 21.50 9.50 2 2 2 2 1 3.30 4 2 1
 4 2 3 1 1 3 
gunasundari      439621g  260 1 2 1 2 1 1 2
 10.40 20.50 10.10 2 2 2 2 2 3.13 4 2 3
 4 2 3 1 1 3 
ammu             061546G  261 1 2 1 2 1 1 2
 12.00 22.41 10.41 2 2 2 2 1 3.22 4 2 3
 4 2 3 1 1 3 
shoba            132594c  262 2 2 1 4 1 5 2
 12.00 22.31 10.31 2 2 2 2 2 3.21 4 2 3
 4 2 3 1 1 3 
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suganya          245780g  263 1 2 1 2 2 5 2
 10.30 15.40 5.20 2 2 2 1 1 3.59 4 2 3
 4 2 3 1 1 3 
jessi            266077g  264 2 2 1 2 1 1 2
 12.00 26.17 14.17 2 2 2 2 1 3.07 4 2 3
 4 2 3 1 1 3 
sasikala         288130g  265 1 2 3 1 1 1 2
 11.00 14.50 4.50 1 2 1 3 2 3.10 1 2 3
 3 2 3 1 1 1 
meenakshi        289751g  266 2 2 3 2 1 1 2
 10.00 22.43 12.43 2 2 2 2 1 3.13 4 2 3
 4 2 3 1 1 3 
durgadevi        329619g  267 1 2 1 2 2 1 2
 9.00 16.38 7.38 2 2 2 1 2 2.90 4 2 3
 4 2 3 1 1 3 
jayalakshmi      330534g  268 2 3 2 4 1 3 1
 12.00 21.10 9.10 2 2 2 3 1 2.40 1 2 3
 4 2 3 1 1 3 
sugashini        342185g  269 1 2 1 2 2 1 2
 12.00 23.08 11.08 2 2 2 1 2 3.08 4 2 3
 4 2 3 1 1 3 
shakira          344759g  270 1 2 1 2 1 2 2
 10.00 22.29 12.29 2 2 2 1 1 3.00 4 2 3
 4 2 3 1 1 3 
anjaly           737689d  271 1 2 1 2 2 1 2
 8.00 16.30 8.30 2 1 2 2 1 3.10 4 2 3
 4 2 3 1 1 3 
jeeva            507029g  272 2 2 1 2 1 1 2
 6.00 11.49 5.49 1 2 1 3 1 3.08 1 2 3
 4 2 3 1 1 1 
prameela         363638g  273 2 2 3 2 1 1 2
 12.00 19.25 7.25 2 2 2 1 1 3.41 4 2 3
 4 2 3 1 1 3 
105 
 
naziya           393984g  274 1 2 1 4 1 5 2
 6.00 18.00 12.00 2 2 2 3 1 3.32 1 2 3
 4 2 3 1 1 3 
lavanya          364356g  275 2 2 3 1 1 2 2
 12.00 20.36 8.36 2 2 2 1 1 2.48 4 2 3
 4 2 3 1 1 3 
rithu            365552g  276 1 2 2 2 2 1 2
 8.00 19.43 11.43 2 2 2 1 2 3.34 4 2 3
 4 2 3 1 1 3 
yasmeen          367117g  277 2 2 1 2 2 5 2
 10.30 16.41 6.11 2 2 2 3 2 3.80 1 2 3
 4 2 3 1 1 3 
chitra           367653g  278 1 2 2 4 1 1 2
 7.00 16.16 9.16 2 2 2 1 2 3.10 4 2 3
 4 2 3 1 1 3 
akila            369406g  279 2 2 2 2 2 1 2
 8.00 15.44 7.44 2 2 2 3 2 2.98 1 2 3
 4 2 3 1 1 3 
ramya            370487g  280 1 2 1 2 1 1 2
 9.40 17.35 8.35 2 2 2 3 2 2.66 1 2 3
 4 2 3 1 1 3 
anu              706629d  281 2 3 1 4 1 2 2
 12.00 19.29 7.29 1 2 2 2 2 2.89 4 2 3
 4 2 3 1 1 3 
divya            347409g  282 1 2 3 4 1 1 2
 11.00 18.03 7.03 2 2 2 1 2 2.78 4 2 3
 4 2 3 1 1 3 
sakthivani       348231g  283 2 2 1 2 1 1 2
 9.45 15.56 6.11 2 2 2 1 2 3.26 4 2 3
 4 2 3 1 1 3 
mohana           349530g  284 1 2 1 4 2 1 2
 8.00 13.00 5.00 2 2 2 2 2 3.11 4 2 3
 4 2 3 1 1 3 
106 
 
chandramma       355790g  285 2 2 2 2 1 1 2
 12.00 20.33 8.33 2 2 1 3 2 3.50 2 2 3
 3 2 3 1 1 3 
reddy            380928g  286 2 1 3 2 1 5 2
 12.00 24.30 12.30 2 2 2 3 1 2.98 2 1 1
 4 2 3 1 1 3 
kalpana          354308g  287 2 2 1 2 2 1 2
 10.00 15.40 5.40 2 2 2 1 1 3.68 4 2 3
 4 2 3 1 1 3 
sumiya           352667g  288 1 2 1 2 2 1 2
 12.00 18.59 6.59 2 2 2 2 1 2.93 4 2 3
 4 2 3 1 1 3 
bharatipriya     469310g  289 2 2 1 4 1 1 2
 12.00 20.45 8.45 2 2 2 1 2 3.60 4 2 3
 4 2 3 1 1 3 
mandeela         507902g  290 1 3 3 4 1 1 2
 11.30 21.51 10.21 2 2 2 2 2 2.63 4 2 2
 4 2 3 1 1 3 
pushpanjali      468583g  291 2 2 1 2 2 1 2
 12.00 22.42 10.42 2 2 2 1 2 3.63 4 2 1
 1 2 2 1 1 3 
prateeba         457734g  292 1 2 1 4 1 1 2
 10.00 16.11 6.11 2 2 2 1 1 2.92 4 2 3
 4 2 3 1 1 3 
maseeha          395319g  293 1 2 2 4 1 2 2
 12.00 19.13 7.13 2 2 2 1 1 3.15 4 2 3
 4 2 3 1 1 3 
rubina j         507934g  294 2 2 1 2 1 1 2
 10.00 14.00 4.00 2 2 2 3 2 2.50 1 2 3
 4 2 3 1 1 3 
bhuvaneswari     493017g  295 2 2 1 2 2 1 2
 12.00 24.24 12.24 2 2 2 1 2 3.48 4 2 3
 4 2 3 1 1 3 
107 
 
susmitha         241023g  296 1 2 3 4 1 1 2
 13.00 23.40 10.40 2 2 2 2 2 2.85 4 2 3
 4 2 3 1 1 3 
shobha           132594C  297 1 2 1 2 2 1 2
 11.00 21.31 10.31 2 2 2 1 2 3.21 4 2 3
 4 2 3 1 1 3 
fatima           975782f  298 1 1 2 2 2 1 2
 10.00 15.03 5.03 2 2 2 1 2 3.34 4 2 3
 4 2 3 1 1 3 
amreen           507972g  299 2 2 1 2 1 1 2
 12.00 22.00 10.00 2 2 2 1 2 2.40 4 2 3
 4 2 3 1 1 3 
almas            380244g  300 1 2 2 2 1 5 2
 10.00 21.30 11.30 2 2 2 2 2 3.01 4 2 3
 4 2 3 1 1 3 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
    
